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Program 
 
Friday 25th May  
Session 1   Chair:  Alessandro Tossi (University of Trieste) 
09.00 – 09.20  Anna Maria Pirttilä (University of Oulu, NAM project coordinator)   
 Opening address. 
09.20 – 9.50    Gerald Bills (Fundación MEDINA, Granada) Endophytic fungal antibiotics: 
discovery, profiles and mechanisms of action. 
9.50 – 10.20    William M. Shafer (Emory University School of Medicine, Atlanta) How 
bacteria modulate their susceptibility to AMPs - implications for anti-
infective development and pathogenesis. 
10.20 – 10.40    Mysore V. Tejesvi (University of Oulu, NAM project) Antimicrobial peptides 
from endophytes. 
Coffee break 
 Chair:  Anna Maria Pirttilä (University of Oulu) 
11.10 – 11.40   Delphine Destoumieux (CNRS, Montpellier) AMPs from marine 
invertebrates 
11.40 – 12.10   Margherita Sosio (NAICONS scarl, Milan) From discovery to development 
of novel antibiotics at NAICONS.  
12.10 – 12.30   Pere Picart (University of Bonn, NAM project)  Piceasin 3 - a new plant 
defensin isolated from Picea glauca. 
Lunch  
 
Session 2 Chair:  Maria Luisa Mangoni (University of Rome, La Sapienza)   
14.00 – 14.30   Ralf Hoffmann (University of Leipzig) Optimization of insect-derived 
antimicrobial peptides to treat systemic bacterial infections. 
14.30 – 15.00   Marco Scocchi (University of Trieste, NAM project)  The PRAMP  story -  
towards an understanding of translocation and activities of Proline-rich AMPs. 
15.00 – 15.30   Heike Brötz-Oesterhelt (University of Düsseldorf)  Lipopeptides with novel  
antibacterial mechanisms or target binding modes. 
 
Coffee break and posters   
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Session 2 (cont.) Chair:  Margherita Zanetti (University of Udine) 
17.00 – 17.30  Maria Luisa Mangoni (University of Rome, La Sapienza)  Short 
membrane-active  peptides from amphibian skin to fight microbial 
pathogens 
17.30 – 18.00  Lidia Feliu (University of Girona) Antimicrobial peptides for plant 
protection 
Saturday 26th May  
Session 3 Chair: Wiliam M. Shafer (Emory University School of Medicine) 
09.00 – 9.30  Gregor Anderluh (National Institute of Chemistry Slovenia)  Looking at 
peptides’ and proteins’ adventures on membranes using surface 
plasmon resonance 
09.30 – 10.00    Alessandro Tossi (University of Trieste, NAM project)  Breach or passage - 
on the multiple modes of antibacterial action of mammalian AMPs 
10.00 – 10.30    Francesca D’Este (University of Udine)  Cathelicidin effects on host cells: 
on the multiple functions of AMPS  
Coffee break 
 Chair: Ralf Hoffmann (University of Leipzig) 
11.00 – 11.30  Francesca Bernardini (Polyphor Ltd, Allschwil CH)  From the natural 
antimicrobial peptide Protegrin-1 to a novel class of anti-
Pseudomonas antibiotics 
11.30 – 12.00 Ana Veiga (University of Lisbon)  Correlating molecular biophysics and 
microbiology using AMPs 
12.00 – 12.30  Tania Schneider (University of Bonn, NAM project)  Cell wall-directed 
actions of AMPs  
Lunch 
Session 4 Chair: Tatiana Ovchinnikova (Shemyakin-Ovchinnikov Inst., Russian Acad. Sci.) 
14.00 – 14.30  Chiara Falciani (SetLance SRL, Siena)  The branched antimicrobial 
peptide M33. A new drug against Gram-negative bacteria? 
14.30 – 15.00  Karoline Sidelmann Brinch (Novozyme A/S, NAM project)  Non-medical 
applications for AMPs 
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Brief participant talks 
15.00 - 15.15 Karl Lohner (Austrian Academy of Sciences, Graz) Multiple membrane 
interaction sites of antimicrobial (lipo)peptides 
15.15 - 15.20 Alberto Pallavicini (University of Trieste)  How many defence peptides in 
Mytilus spp? 
Coffee break and posters 
 Brief participant talks Chair: Renato Gennaro (University of Trieste) 
16.30 - 16.45 Davor Juretić (University of Split) In silico search strategies for finding 
new AMPs  
16.45 - 17.00 Lorenzo Alibardi (University of Bologna) Beta-defensins in the soft-
shelled turtle Apalona spinifera 
17.00 - 17.15 Anton Polyansky (University of Vienna and Russian Academy of Sciences) 
Conformational dynamics study of lantibiotics-lipid II interactions. 
17.15 - 17.30 Antonello  Romani (Surgery O.U., University Hospital Parma) A Novel 
Terapeutic Agent Against Gram-Negative Infections In Cystic  Fibrosis 
 
17.30 Hans-Georg Sahl (University of Bonn, NAM project) Closing remarks  
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PRESENTATION ABSTRACTS 
 
       Oral presentations 
 
1)  Opening address 
 Anna Maria Pirttilä  (University of Oulu, Finland; NAM Project Scientific Coordinator). 
 Antibacterial resistance is spreading globally at an alarming rate and continues to 
increase. New potent antibacterial agents and therapies are therefore continually 
needed. In recent years, new antibacterial compounds have mainly been additions to 
the existing classes of drugs and truly new structures have rarely been developed. 
Pharmaceutical industry has little interest in developing new structures due to high 
investment and low profit expectancy. The derivatives of existing drugs however 
raise bacterial resistance much faster than completely new compounds. To overcome 
the chronic problem of antibiotic resistance, totally new compounds and approaches 
are required, involving collaboration of researchers from various disciplines, as well 
as high societal investments. 
 The NAM (New Antimicrobials) Project is funded by the Marie Curie Actions of 
the EU Seventh Framework Programme. The aim was to foster collaboration and 
exchange of personnel between academic groups and companies working on various 
aspects of antimicrobials: new sources, new approaches and mode-of action. This is 
the second Workshop organised within the NAM project and its aim is to coalesce the 
experience of NAM project members with that of participants from other academic 
and industry groups.  
2) Endophytic fungal antibiotics: discovery, profiles and mechanisms of action. 
Gerald F. Bills (Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos 
Innovadores en Andalucía, Parque Tecnológico de Ciencias de la Salud, Granada, Spain) 
 Our lab has developed a suite of integrated tools for high-throughput and species-specific 
culturing of plant-associated filamentous fungi [1], complementary fermentation methods to 
manipulate fungal secondary metabolism [2-4], and phylogenetic and mass spectrometry 
recognition of known antibiotics [5]. Growth of fungi in nutritional arrays, the parallel growth of 
strains across multiple growth parameters in microplate fermentations, increases the 
probability of detecting antibiotic signals against Candida albicans and pathogenic bacteria and 
more thoroughly exploits the metabolic potential of strains. Complementing nutritional arrays 
with other methods, e.g. fungal growth in chemically inert solid matrices [3] or adsorptive resins 
[2], likewise enables a more exhaustive search for antibiosis across the filamentous fungi. 
Known and potentially unknown fungal-produced antibiotics are detected by LC-MS database 
matching so that chemical isolation work is focused on the most novel chemistry. Results are 
mapped onto a DNA barcode phylogeny [5]. Phylogenetic mapping has corroborated 
hypotheses about fungal secondary metabolism gleaned from genomic data and has directly 
confirmed that antibiosis is a universal and essential trait of the filamentous fungal life cycle. 
Plant-associated fungi exhibiting significant antibiosis towards model pathogens, C. albicans and 
Staphylococcus aureus, have been scaled up to produce enough antibiotic extract to generate 
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hypothetical mechanism of action profiles in genome-wide fitness tests in C. albicans and S. 
aureus, a subsequently often yielding novel metabolites [6, 7].The strategies have revealed new 
patterns of secondary metabolite distribution among plant-associated fungi while contributing 
to the discovery of several new antibiotics with new mechanisms of action. The platform will 
find utility in genomic mining for products of cryptic metabolite pathways. 
1. Collado, J., G. Platas, B. Paulus, and G.F. Bills, High-throughput culturing of fungi from plant litter by a 
dilution-to-extinction technique. FEMS Microbiol Ecol, 2007. 60: 521–533. 
2. de la Cruz, M., J. Martín, V. González-Menéndez, I. Pérez-Victoria, C. Moreno, J.R. Tormo, N.E. Aouad, J. 
Guarro, F. Vicente, F. Reyes, and G.F. Bills, Chemical and physical modulation of antibiotic activity in 
Emericella species. Chem Biodivers, 2012. in press. 
3. Bills, G.F., A.W. Dombrowski, and M.A. Goetz, The “FERMEX” method for metabolite-enriched fungal 
extracts. Meth Molecul Biol, 2012. In press. 
4. Bills, G., G. Platas, A. Fillola, M.R. Jiménez, J. Collado, F. Vicente, J. Martín, A. González de Val, J. Bur-
Zimmermann, J.R. Tormo, and F. Peláez, Enhancement of antibiotic and secondary metabolite detection 
from filamentous fungi by growth on nutritional arrays. J Appl Microbiol, 2008. 104: 1644–1658. 
5. Vicente, F., A. Basilio, G. Platas, J. Collado, G.F. Bills, A. González del Val, J. Martín, J.R. Tormo, G.H. Harris, 
D.L. Zink, M. Justice, J. Nielsen Kahn, and F. Peláez, Distribution of the antifungal agents sordarins across 
filamentous fungi. Mycol Res, 2009. 113: 754-770. 
6. Goetz, M.A., C. Zhang, D.L. Zink, M. Arocho, F. Vicente, G.F. Bills, J. Polishook, K. Dorso, R. Onishi, C. Gill, E. 
Hickey, S. Lee, R. Ball, S. Skwish, R.G.K. Donald, J.W. Phillips, and S.B. Singh, Coelomycin, a highly 
substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus 
aureus fitness test profiling. J Antibiot, 2010. 63: 512-518. 
7. Roemer, T., D. Xu, S.B. Singh, C.A. Parish, G. Harris, H. Wang, J.E. Davies, and G.F. Bills, Confronting the 
challenge of natural product-based antifungal discovery. Chem Biol, 2011. 18: 148-164. 
3)  How bacteria modulate their susceptibility to AMPs - implications for anti-infective 
development and pathogenesis. 
 William M.  Shafer (Emory University School of Medicine, Atlanta, GA)  
 AMPs are important mediators of innate host defense during infection. Given the 
antibiotic-like properties of AMPs, it is not surprising that microbes have evolved 
mechanisms to counteract their action. I will discuss systems used by human 
pathogenic bacteria to thwart the action of AMPs. I will discuss how these 
mechanisms of AMP resistance impact in vivo fitness and survival of pathogens 
during infection. In a larger context, I will discuss how AMP-resistance systems should 
be accounted for in the development of new therapeutics. 
4)  Antimicrobial peptides from  endophytes. 
Tejesvi MV
a
, Picart P
a
, Koskimaki, J
a
, Ruddock L
a
, Tossi A
b
, , Kristensen HH
c
, Segura DR
c
, 
Andersen B
c
, Schnorr KM
c
, Olsen PB
c
, Neve S
c
 Kajula M
a
, Hautajärvi H
a
, Mattila S
a
, 
Pirttilä AM
a
  (
a
Department of Biology, University of Oulu, Finland; 
b
Department of Life 
Sciences, University of Trieste, Italy; 
c
Novozymes A/s, Bagsvaerd, Denmark; NAM 
Project Members) 
 Endophytes are the microbes which live inside the plants without causing any 
symptom of disease. Endophytes are well known for the production of novel and 
biologically active metabolites, which have application in agriculture, medicine and 
pharmaceutical industry. Staphylococci, Mycobacteria, Streptococci and Enterococci 
have developed drug resistance and this is a growing threat to world health, 
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prompting us to look for better antibiotics from new sources such as endophytes. 
There are many antibiotics already isolated and identified from endophytes, such as 
Coronamycins, Munumbicins and Leucinostatin A. We have isolated one antifungal 
and two antibacterial peptides from endophytes using metagenomics, transcriptimcs 
and genome sequencing tools. 
5)   AMPs from marine invertebrates (AMPs in the defense of the Pacific oyster 
- how diversity may compensate for scarcity in the regulation of 
resident/pathogenic microflora).  
Delphine Destoumieux, Paulina Schmitt, Rafael Diego Rosa, Marylise Duperthuy, 
Julien de Lorgeril, Evelyne Bachère (CNRS, Montpellier, France) 
 Antimicrobial peptides and proteins (AMPs) participate in the antimicrobial 
defense of living organisms, protecting hosts from invasion by pathogens and 
regulating homeostasis. In Crassostrea gigas oysters, four families of gene- encoded 
AMPs have been described to date, namely defensins (CgDefs), proline-rich peptides 
(Cg-Prps), big defensins (CgBigDefs) and bactericidal permeability/increasing proteins 
(Cg-BPIs). Unlike in many other marine invertebrates, oyster AMPs are produced at 
low concentrations. They are expressed by epithelial cells and/or circulating 
hemocytes. In non-diseased oysters, which are normally populated by an abundant 
resident microflora, hemocytes express basal levels of Cg-Defs and Cg-Prps that could 
participate in homeostasis. Upon infection, both AMP families are driven to sites of 
infection by major hemocyte movements, together with Cg-BPI and given CgBigDef 
forms, whose expression in hemocytes is induced by infection. Co-localisation of 
AMPs at sites of infection could be determinant in limiting invasion. Indeed, synergies 
have been evidenced between peptide families, which are potentiated by the 
considerable diversity of sequences within the Cg-Def and Cg-Prp families. Besides, 
diversity takes place at the level of oyster AMP mechanisms of action, which range 
from membrane lysis for Cg-BPI to inhibition of metabolic pathways for Cg-Defs. We 
believe that the combination of such different mechanisms of action may account for 
the synergistic activities observed and compensate for the low peptide 
concentrations in C. gigas cells and tissues. The success of infection by pathogens 
could then rely on subtle mechanisms of resistance and evasion of the oyster 
antimicrobial response. Some Vibrio strains pathogenic for oysters are equipped with 
AMP-sensing systems that trigger resistance. In addition, oyster pathogens have 
developed diverse mechanisms to resist/evade intracellular killing through 
phagocytosis and the associated oxidative burst.  
6)   From discovery to development of novel antibiotics at NAICONS.  
 Margherita Sosio (NAICONS scarl, Via Fantoli 16/15, 20138 Milan, Italy) 
NAICONS (New Anti-Infectives Consortium) is an organization aimed at 
integrating resources for the discovery and development of new bioactive 
compounds, particularly antibiotics for serious infections caused by multi-drug 
resistant pathogens. Naicons' portfolio includes new antibacterial products at the 
late preclinical/early clinical stage. Our drug discovery programs are based on a 
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technological platform based on a collection of over 65,000 secondary metabolites 
producing microorganisms, which includes many rare and hard to isolate strains, and 
the know-how to exploit this resource. The company explores this potential source of 
chemical diversity by using rationales that increase the chances of finding new 
natural products. One approach consists of screening previously (under)explored taxa 
of Actinobacteria by simple growth-inhibition assays, followed by the rapid 
assessment of chemical novelty by a combination of analytical techniques and 
database queries. One particularly promising taxon is represented by the genus 
Actinoallomurus. A pilot study on 50 strains from this genus has unveiled different 
classes of secondary metabolites, including new compounds at a high frequency. 
Naicons is also involved in the development of the antibiotics NAI-107 and NAI-acne. 
The lantibiotic NAI-107, produced by the actinomycete Microbispora sp., has the 
potential to treat life-threatening infections caused by multidrug-resistant Gram-
positive pathogens and is currently undergoing formal toxicology studies. Naicons is 
coordinating an FP7 project aimed at the optimization of the production process. 
NAI-Acne is a semisynthetic derivative of the thiazolylpeptide GE2270, produced by 
the actinomycete Planobispora rosea, which exibits a restricted antibacterial 
spectrum covering mostly Propionibacterium acnes. Also in this case, its development 
can benefit from the optimization of the production process, for which Naicons is 
coordinating a project supported by Regione Lombardia. During this project, we were 
able to obtain heterologous production of GE2270 and have started manipulating its 
biosynthetic pathway. 
7)  Piceasin 3 - a new plant defensin isolated from Picea glauca.  
 Pere Picart (Institute of Microbiology and Biotechnology, University of Bonn, Germany,  
NAM Project member). 
A novel defensin gene was found by screening the available Picea glauca EST 
database with the BLAST algorithm. A PCR-based strategy was used to isolate the 
gene Pgd3 using genomic DNA extracted from P. glauca. Pgd3 encoded for a 77 
amino acid peptide with sequence homology to the family of plant defensins and was 
fully conserved within Picea genus. Pgd3 peptide, produced in Escherichia coli 
origami by SUMO technology, had a molecular mass of 5.721 kDa as determined by 
mass spectrometry. Recombinant Pgd3 was very high heat-stable, moderately 
inhibited by divalent cations and showed strong antifungal activity against a broad 
spectrum of plant pathogenic fungi and Saccharomyces cerevisiae, with very high 
levels of activity against the wilting disease causing pathogen Verticillium dahliae, 
and Botrytis cinerea, one of the most important pathogens of coniferous trees. The 
Pgd3 peptide did not induce morphological changes on the treated fungal hyphae, 
but instead strongly inhibited hyphal elongation. A SYTOX uptake assay suggested 
that the inhibitory activity of Pgd3 might be associated with altering the membrane 
permeability of the fungal membranes. 
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8)  Optimization of insect-derived antimicrobial peptides to treat systemic bacterial 
infections.  
 Ralf Hoffmann, Uwe Müller, Eszter Ostorhazi, Daniel Knappe, Michael Zahn, Annegret Binas, 
Oliver Nolte, Norbert Strater, Gottfried Alber (Biotechnology and Biomedicine Centre, University 
of Leipzig) 
The emergence of multi-drug resistant bacterial pathogens in hospitals 
(nosocomial infections) presents a global threat of growing importance, especially for 
Gram-negative bacteria in recent years. Our lead compound Api88 was developed in 
an iterative approach to optimize the native antimicrobial peptide (AMP) apidaecin 
1b (produced by honeybee Apis mellifera) for increased antibacterial activities 
against threatening human pathogens, such as Escherichia coli, Klebsiella 
pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii while 
maintaining the favorable properties of the original sequence, i.e. no hemolytic 
activity and no toxicity against mammalian cells. Api88 appears to kill bacteria by the 
same mode of action as native Pro-rich peptides without lytic effects on cell 
membranes. It binds with a seven residue long stretch in two different modes to the 
chaperone DnaK at the substrate binding domain with KD-values around 6 µmol/L.  
9) The PRAMP story -  towards an understanding of translocation and  
 activities of Proline-rich AMPs.  
Marco Scocchi, Monica Benincasa, Giulia Runti, Mario Mardirossian, Renato Gennaro 
(Department of Life Sciences, University of Trieste, NAM Project member) 
 Among the galaxy of different AMPs the Proline-rich (PR-AMPs) are a group of cationic 
peptides with peculiar features. Although not evolutionary related, PR-AMPS of both 
vertebrates and invertebrates are characterized by short repeated stretches of proline and 
arginine residues, they selectively kill Gram-negative bacteria and are relatively non toxic 
towards host cells. Most PR-AMPs have a similar mechanism of action based on the 
inhibition of largely unknown intracellular targets, while damage to bacterial membranes, 
unlike many other types of AMPs, is only a secondary effect.  
 In this study we used Bac7(1-35), an active fragment of a mammalian PR-AMP to further 
investigate the mechanism of action of this group of peptides. By the screening of E. coli 
mutant libraries with decreased susceptibility to Bac7 we identified SbmA, an inner 
membrane protein necessary for the transport of Bac7(1-35) and other PR-AMPs to the 
bacteria, whose deletion caused a marked reduction in peptide susceptibility. Our results 
indicate that SbmA is a low-specificity active carrier of peptides with unknown function 
sharing some feature with the ABC transporters and used by host to introduce AMPs into the 
bacteria. By in vitro affinity binding assays we isolated the heat shock protein DnaK as a first 
intracellular interactor of Bac7(1-35). Although in vitro interaction with the peptide inhibited 
the refolding activity of DnaK molecular chaperone system, a DnaK-deficient strain was not 
significantly affected by the peptide indicating that other vital targets are present in 
susceptible bacteria. Since DnaK has previously been identified as a target of insect PR-AMPs, 
our observation indicates an interesting convergence in the mode of action of PR-AMPs both 
with respect to the transport system and internal target. 
 16 
Overall these results make PR-AMPs attractive both as anti-infective lead compounds and as 
a new class of bacteria-penetrating peptides potentially capable of internalizing membrane-
impermeant drugs.  
10) Lipopeptides with novel antibacterial mechanisms or target binding modes. 
Heike Brötz-Oesterhelt (Institute for Pharmaceutical Biology and Biotechnology, Heinrich-Heine 
University of Düsseldorf, Germany)  
 Multi-drug-resistant bacteria are spreading within hospitals world-wide and expand into 
the community. New therapeutic options are continually needed to maintain our 
therapeutic standard in the treatment of bacterial infections. Our current research focuses 
on several natural product antibiotics from novel structural classes with resistance breaking 
properties. We elucidate their molecular mechanisms of action to identify innovative 
principles for antibiotic intervention and we evaluate their qualification as lead structures for 
antibiotic development. 
 Novel acyldepsipeptides designated ADEPs show promising activity against important 
Gram-positive bacteria. They act by an unprecedented target, the bacterial caseinolytic 
protease ClpP [1]. Rather than inhibiting their target, the antibiotics deregulate and over-
activate it. By abrogating the interaction of ClpP with cooperating and regulatory partner 
molecules, all normal functions of ClpP in general and regulatory proteolysis are prevented 
and un-physiological substrates are untimely degraded [2], among these the important cell 
division protein FtsZ [3]. Structures of ADEP-ClpP complexes unravel the conformational 
changes that convert ClpP from a strictly controlled precision instrument to a general protein 
shedder [4]. 
In contrast, the lipodepsipeptide empedopeptin acts within the classical metabolic pathway 
of bacterial cell wall synthesis on a well known and highly validated target, the peptidoglycan 
precursor lipid II. The region of lipid II that is recognised by empedopeptin is distinct from 
that of the marketed antibiotic vancomycin, thereby omitting cross-resistance [5]. 
[1] Brötz et al. 2005, Nat. Med. 11: 1082-87 
[2] Kirstein et al. 2009, EMBO Mol. Med. 1: 37-49 
[3] Sass et al. 20011, Proc. Natl. Acad. Sci. 108: 17474-17479 
[4] Lee et al. 2010, Nat. Struct. Mol. Biol. 1787: 1-8 
[5] Müller et al. 2012, J. Biol. Chem. (epub. ahead of print) 
11)  Short membrane-active peptides from amphibian skin to fight microbial pathogens. 
 Maria Luisa Mangoni (University of Rome, La Sapienza, Italy)  
 Amphibian skin secretions represent a rich source of antimicrobial peptides (AMPs). In 
particular, temporins constitute a large family and are among the smallest amphipathic α-
helical AMPs (10-16 residues) found in nature to date, and with the lowest number of positively 
charged amino acids [1]. Some of them possess unique properties including: (i) a fast 
membranolytic effect against a large spectrum of microorganisms; (ii) synergism, when 
combined one with the other, in inhibiting bacterial growth and in endotoxin  neutralization 
[2,3].  
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Another interesting ,small-sized and membrane-active AMP is esculentin(1-18) corresponding 
to the N-terminal 1-18 fragment of esculentin-1b, isolated from frog skin. It displays a rapid 
bactericidal activity against important nosocomial pathogens, such as the Gram-negative 
Pseudomonas aeruginosa. Its in vivo antimicrobial activity and mode of action have been 
studied using the mini-host model of Caenorhabditis elegans infected by a multidrug-resistant 
strain of P. aeruginosa [4]. Furthermore, promising results have been obtained from peptide-
treatment of cows with clinical mastitis. Overall, these studies suggest frog-skin AMPs as 
attractive molecules to assist in the future design and manufacturing of new peptide-based 
anti-infective drugs.  
1. Mangoni, M. L. and Shai Y. Cell Mol Life Sci. 2011; 68:2267-80. 
2. Mangoni ML et al. J. Biol Chem. 2008; 283:22907-17 
3. Bhunia A, et al. J. Biol Chem. 2011; 286:24394-406 
4. Uccelletti D. et al. Antimicrob Agents Chemother. 2010;54:3853-60. 
12) Antimicrobial peptides for plant protection 
Lidia Feliu, Esther Badosa, Jordi Cabrefiga, Jesús Francés, Eduard Bardají, Emilio 
Montesinos, Marta Planas (LIPPSO,  University of Girona, Spain) 
 The main objective of our research is focused on finding peptides as new agents 
to control economically important plant pathogenic bacteria and fungi for which the 
available methods are not sufficiently effective. In particular, we are interested in the 
bacteria Erwinia amylovora, Pseudomonas syringae and Xanthomonas vesicatoria, 
and the fungi Fusarium oxysporum and Penicillium expansum. Nowadays, the control 
of these mincroorganisms is mainly based on copper compounds and antibiotics, 
which have some limitations and a high environmental impact. On the other hand, 
antibiotics are not authorized in several countries and resistance has developed in 
plant pathogens. The identification of peptides able to fight the above bacteria and 
fungi will represent an alternative to currently used antibiotics or pesticides. The 
main features expected for these peptides are a high antimicrobial activity, a low 
eukaryotic cytotoxicity and a high stability to protease digestion. 
 We have synthesized combinatorial libraries of cyclic decapeptides and linear 
undecapeptides. These libraries have been screened for antibacterial activity and 
eukaryotic cytotoxicity, which has led to the identification of lead peptides. The 
biological profile of these peptides has been further improved by incorporating 
several modifications into their sequences. These modifications and their influence in 
the biological activity will be discussed. 
 
13)  Looking at peptides’ and proteins’ adventures on membranes using surface 
plasmon resonance 
Gregor Anderluh
1
 and Vesna Hodnik
2
 (
1
National Institute of Chemistry and 
2
University 
of Ljubljana, Biotechnical Faculty, Department of Biology, Ljubljana, Slovenia, 
Ljubljana, Slovenia) 
 Surface plasmon resonance (SPR) is one of the most important biophysical 
approaches to study molecular interactions. Most of the published literature 
describes this approach to study protein-protein interactions. Protein-membrane and 
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peptide-membrane interactions, although crucial for many cell processes, are less 
well studied. The most obvious advantages of SPR over other techniques are direct 
and rapid determination of association and dissociation rates of binding process, no 
need for labelling of protein or lipids, and low amount of sample that is used in the 
assay (nM concentrations for proteins). 
 In a typical experiment, a membrane is prepared on the surface of so-called 
sensor chip and the protein or peptide is passed over. Different approaches to 
membrane immobilization were described and will be briefly reviewed in this lecture. 
It is possible to immobilize intact liposomes on the chip. It is easy to reproducibly 
prepare stable lipid surface under various experimental conditions, i.e. temperature 
or pH. SPR also allows studying binding to more complex membrane preparations 
derived from cells, such as intracellular vesicles preparations, red blood cell ghosts, 
etc. In the last few years SPR was, therefore, used to study membrane binding of 
peripheral proteins participating in membrane-mediated cell signalling, membrane 
binding toxins and peptides, etc. 
14)  Breach or passage - on the multiple modes of antibacterial action of   
 mammalian AMPs 
Alessandro Tossi, Nikolinka Antcheva, Daniela Xhindoli, Filomena Guida, Mario 
Mardirossian, Marco Scocchi and Renato Gennaro (Department of Life Sciences, 
University of Trieste, Italy, NAM Project member)   
 Two of the principal families of mammalian antimicrobial/host defence peptides are 
the cathelicidins and β-defensins. Cathelicidins are characterized by a conserved pro-
region carrying antimicrobial peptides with differentiated sizes and structures, including 
amphipathic, helical AMPs and proline/arginine rich peptides (PRAMPs) with extended 
structures. β-defensins have more complex S-S bridged structures consisting of a small β-
sheet onto which a helical segment is often packed. These peptides have a multimodal 
capacity to directly inactivate microbial pathogens, and can also act indirectly by 
modulating other host immune and healing responses. Their evolutionary patterns range 
from conservation to positive selection for variation, suggesting that they may have 
adapted their structures and mechanisms of action to cater for different roles in host 
defence. 
 An initial interaction with biological membranes is a common and central theme in 
modulating the activities of all these types of AMPs, although this subsequently leads to 
quite different effects (membrane lysis, translocation or binding to a membrane 
component). To better understand these processes, we are carrying out a systematic 
analysis of factors affecting the modes-of-action of the human β-defensins hBD2 and 3, 
the human helical AMP LL-37 and its primate orthologues, and the bovine PR-AMP Bac7. 
These studies involve the rational design of unnatural analogues to better understand the 
roles of key structural features in the peptides, the use of membrane models to probe 
how these mediate membrane interactions, and the use of bacterial strains with specific 
surface characteristics as tools to probe the mode-of-action. 
 Our results indicate interesting convergences and divergences in the way that the 
different types of AMPs interact with membranes, and how this affects subsequent 
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biological activities. LL-37 and hBD3 are differentially active against both Gram-positive 
and -negative bacteria and appear to act principally at the microbial surface, eventually 
leading to membrane breaching. Bac7 is selectively active against Gram-negative bacteria 
and is internalised by a protein transporter to act on an internal target, without an 
apparent damage to bacterial membranes. Nonetheless, key residues required for its 
transport also mediate its capacity to reach the transporter by interacting with the 
bacterial membranes. For the β-defensins and LL-37, self-aggregation and the presence of 
an amphipathic helical domain both affect the efficiency of membrane approach and 
interaction, the selectivity for microbial or host membranes, and ultimately may 
determine whether the peptides act principally via a direct, membranolytic antimicrobial 
mechanism, or through other types of mechanisms involving immune stimulation. 
15)  Cathelicidin effects on host cells: on the multiple functions of AMPs 
 Francesca D’Este, Linda Tomasinsig, Barbara Skerlavaj, Andrea Sgorbissa, Cristina 
Bergnach and Margherita Zanetti (Department of Medical and Biological Sciences, 
University of Udine, Italy) 
 Accumulating evidence indicates that the role of the antimicrobial peptides (AMPs) in 
host defence extends far beyond that of simple endogenous antibiotics. This concept is 
well illustrated by the multiple activities exhibited in vitro and under clinical conditions by 
the human cathelicidin LL-37. This AMP has been shown to stimulate diverse cellular 
processes relevant to inflammation and immunity such as chemotaxis, cellular cytokine 
and chemokine release and angiogenesis. Several protein receptors, also including P2X7, 
FPRL-1, EGFR, have been implicated in these effects. However the mechanistic basis of 
their activation by LL-37 is still not fully understood. We have to some extent investigated 
this issue and have shown that the ability of LL-37 to modulate the function of P2X7 
receptor, a cell surface protein involved in the proliferation-inducing activity of LL-37, is 
strictly dependent on the structural/aggregational properties of LL-37. This finding, 
together with preliminary data indicating ability of LL-37 to specifically interact with the 
transmembrane domain of selected membrane proteins, suggests a noncanonical LL-37-
receptor interaction mediated by the interaction of the peptide with the cell membrane.  
  In several instances, the host cell-directed activities of other alpha helical cathelicidins 
have been shown to differ significantly from those of LL-37. For example, we have shown 
that the bovine congener BMAP-28 exhibits distinct effects on angiogenesis and on cell 
death/cell survival processes such as apoptosis, autophagy and proliferation. Also, BMAP-
28 displays distinctive anti-endotoxin features by impairing the LPS-induced internalization 
of the cellular LPS receptor TLR4 without affecting the function of surface TLR4. As a 
consequence, the activation of the TRAM/TRIF, but not that of the MyD88 TLR4 signalling 
pathway is inhibited. 
16) From the natural antimicrobial peptide Protegrin-1 to a novel class of anti- 
Pseudomonas antibiotics 
 F. Bernardini, G. Dale, S. DeMarco, K. Dembowsky, F. O. Gombert, A. Lederer, C. Ludin, 
P. Misson, A. Wach, J. A. Robinson and D. Obrecht (Polyphor Ltd, 
Hegenheimermattweg 125, CH-4123 Allschwil, Switzerland) 
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 Antibiotics with new modes of action are urgently needed to combat the growing 
health threat posed by resistant pathogenic microorganisms. Antibiotic drug 
discovery in the past two decades has focused efforts on the development of 
antibiotics against Gram-positive bacteria and more specifically against multidrug-
resistant S. aureus (MRSA). In contrast, treatment options against some MDR Gram-
negative pathogens have become very limited, especially due to the emergence of 
resistance against the last resort antibiotics, colistin and polymyxin B. Applying the 
Protein Epitope Mimetics (PEM) Technology, we synthesized a family of 
peptidomimetic antibiotics based on the antimicrobial peptide Protegrin-1. Several 
rounds of optimization gave a family of new antibiotics with potent antimicrobial 
activity specific against Pseudomonas aeruginosa. Biochemical and genetic studies 
showed that these peptidomimetics have a new mode of action and identified the β-
barrel protein LptD (Imp/OstA), which is implicated in the outer-membrane 
biogenesis, as molecular target. Optimized leads show potent antimicrobial activity in 
murine infection models and POL7080 has been selected as the clinical candidate. 
17) Correlating molecular biophysics  and microbiology using AMPs 
 Ana Veiga (University of Lisbon, Portugal) 
 Antimicrobial peptides (AMPs) are small, amphiphilic peptides with a positive net 
charge. An understanding of the mechanism adopted by the AMPs is central to their 
development as a new group of antimicrobial agents. An increasing amount of 
information on the action of AMPs at the molecular level has not yet been translated 
into a comprehensive understanding of effects in bacteria. Although some 
biophysical attributes of AMPs have been correlated with macroscopic features, the 
physiological relevance of other properties has not yet been addressed. Strong 
membrane-binding and micromolar therapeutic concentrations of AMPs indicate that 
membrane-bound concentrations may be reached that are higher than intuitively 
expected, triggering disruptive effects on bacteria. Experimental evidence obtained 
with the AMPs Omiganan and BP100 supports this idea and will be discussed in order 
to bridge the gap between biophysical studies using artificial lipid bilayers and studies 
using bacteria. 
18) Cell wall-directed actions of AMPs  
Tania Schneider (Institute of Microbiology and Biotechnology, University of Bonn, 
Germany, NAM Project member) 
 Antimicrobial peptides serve a vital role in first-line host defence and can be 
found throughout the animal and plant kingdom. Although being evolutionary 
ancient, AMPs have retained antimicrobial efficacy against gram-positive and gram-
negative bacteria, fungi and enveloped viruses. Among the antimicrobial peptides, 
the defensins represent an important peptide family.  
 The fungal defensin Plectasin is a 40 amino acid peptide produced by the 
saprophytic ascomycete Pseudoplectania nigrella. Plectasin shares primary structural 
features with defensins from spiders, scorpions, dragonflies and mussels and folds 
into a cysteine-stabilized alpha-beta-structure. 
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 Unlike conventional antibiotics which act via defined target molecules, 
antimicrobial defence peptides are assumed to act unspecifically by permeabilising 
the cell membrane. In contrast to this widely held view, Plectasin specifically targets 
the bacterial cell wall precursor lipid II, thereby inhibiting cell wall biosynthesis. 
 A series of cellular approaches and in vitro cell wall biosynthesis assays narrowed 
down the target pathway and the specific mechanism of action.  Structural analysis of 
the Plectasin:lipid II complex identified, among others, the N-terminal amino group 
and His18 to contribute to Plectasin binding through interaction with the carboxyl 
group of D-Glu in position 2 of the lipid II stem peptide. In line with this, amidation of 
D-Glu to D-iso-Gln, as characteristically found in the peptidoglycan of staphylococci 
and other gram-positive pathogens, reduced susceptibility towards plectasin.  
19) The branched antimicrobial  peptide M33. A new drug against Gram- 
 negative bacteria? 
Chiara Falciani, Luisa Bracci, Jlenia Brunetti, Stefano Bindi, Barbara Lelli, Silvia Scali, 
Luisa Lozzi and Alessandro Pini (SetLance SRL, Siena, Italy)  
 The antimicrobial peptide M33 derives from the random selection of a 
combinatorial library incubated with E. coli cells and a rational optimization phase 
that produced a peptide with the typical features of antimicrobial peptides. 
 M33 peptide is synthesized in tetra-branched form, a structure that makes 
peptides highly resistant to circulating peptidases, thus becoming particularly 
suitable for in vivo use. M33 peptide is predominantly active against Gram-negative 
bacteria with MIC valuess comparable to many traditional antibacterial agents 
currently used in the clinic. Its mechanism of action has been characterized for 
membrane interaction, pore formation, biofilm eradication, DNA binding and LPS 
neutralization. Neutralization of LPS, demonstrated as a reduction in TNF-alpha 
production by macrophages, is a crucial aspect because it suggests that in vivo the 
peptide is involved not only in the direct killing of bacteria but possibly also in the 
reduction of cytokines that generate inflammation. This aspect, along with the low 
MIC shown by M33 against clinical isolates of P. aeruginosa from patients with Cystic 
Fibrosis or sepsis, increases the interest of this molecule as a new drug for these 
diseases where inflammation triggered by bacterial infection is a major element of 
pathology progression. 
 The current preclinical development of peptide M33 consists of efficacy 
experiments in animal models of sepsis, pneumonia and skin infection. Here we 
present results where strong reduction of bacterial load in-vivo and high animal 
survival rates are obtained through M33 administration.   
20)  Non-medical applications for AMPs  
 Karoline Sidelmann Brinch (Novozymes A/S, denmark,  NAM Project member) 
 In recent times the interest in non-pharma applications for AMP technologies has 
increased significantly. This talk will review some of the possible areas for such 
applications of AMPs and discuss some of the emerging challenges which may 
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present themselves in connection to these uses, including production technologies, 
cost-in-use, regulatory issues among others. 
 
Brief participant presentations 
 
21)   Multiple membrane interaction sites of antimicrobial (lipo)peptides 
Dagmar Zweytick
1
, Günter Deutsch
1
, Yechiel Shai
2
, Jörg Andrä
3
, Sylvie E. Blondelle
4
 
and Karl Lohner
1
 (
1
Inst. of Biophysics & Nanosystems Research, Austrian Academy of 
Sciences, Graz, Austria, 
2
The Weizmann Institute of Science, Israel, 3Research Center 
Borstel, Germany, 4Sanford-Burnham Medical Research Institute, San Diego, USA) 
Although antibiotic resistance has been an increasingly global health problem, the 
number of novel antibiotics on the market has declined steadily. In addition, the threat that 
bacteria being resistant to antibiotics will pass its resistance gene to other pathogens 
creating multidrug resistance emphasizes the need of novel antibiotics.  One promising 
strategy is based on antimicrobial peptides, which mostly do not target single defined 
molecular structures, but act on the cell membrane killing bacteria rapidly within minutes, 
which reduces the likelihood of induced resistance. Understanding the mechanism(s) of 
membrane damage is thus a critical need to design novel antibiotics. 
In general, lipopeptides show an increased activity against bacteria as compared to their 
non-acylated analogue. Hence, we have studied the effect of N-acylation on synthetic 
peptides derived from human lactoferricin on bacteria and membrane mimetic systems 
using various biophysical methods. Linking a hydrophobic moiety resulted in a different 
mode of bilayer perturbation. Massive membrane damage was only observed in the 
presence of N-acylated antimicrobial peptides, visualized by incorporation of the cationic dye 
SYTOX green, which can only enter cells, when its membrane is disrupted. This behaviour 
was also reflected in a stronger degree of membrane destabilization of E. coli and S. aureus 
as well as increased vesicle leakage in the presence of N-acylated antimicrobial peptides. 
However, these findings did not necessarily correlate quantitatively with the antimicrobial 
potency, which in several cases was similar for the N-acylated and its parent peptide. This 
suggests that both types of antimicrobial peptides interact also differently with other targets 
such as lipopolysaccharides in case of Gram-negative bacteria or lipoteichoic acid in case of 
Gram-positive bacteria. Electron micrographs support this notion showing formation of 
extrusions of lipid material, presumably from the outer membrane, in the presence of N-
acylated peptides. Both types of peptides though induced membrane ruffling and 
detachment of the inner and outer membranes clearly indicating a membrane-based mode 
of action that leads to bacterial killing. 
22)   How many defence peptides in Mytilus spp? 
Venier P, Gerdol M, Rosani U, Domeneghetti S, Manfrin C, De Moro G, Pallavicini A, 
(Universities of Trieste and Padova, Italy) 
Mussels of the genus Mytilus are filter-feeder bivalves constantly surrounded by 
potential microscopic invaders in the coastal waters. Like other invertebrates, they can 
account only on rapid and effective innate defences, mainly ascribed to the hemolymph 
cells. HPLC-based evidence of AntiMicrobial cationic Peptides in M. galloprovincialis and 
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M. edulis dates back to 1996 [1,2]. Since then, both Sanger and high throughput 
sequencing have greatly speeded the discovery of precursor transcript variants and 
subsequent functional studies [3]. 
The availability of new sequence data allowed the definition of various DNA 
microarray platforms [4]. The analysis of ESTs included in the Mytibase collection drove 
subsequent amplicon pyrosequencing of the most known M. galloprovincialis mytilins, 
defensins, myticins and mytimycin [5] and revealed in more detail isotype-specific levels of 
variability of the AMP precursor transcripts, irrespective of the geographical mussel origin 
and immunostimulation. Both mechanisms underlying such molecular variation and 
functional meaning remain to be understood. 
The high sequence variability of several AMPs is just one feature of an assorted 
defence repertoire. Illumina and 454 Roche sequencing performed on M. galloprovincialis 
revealed several other short peptides with different putative cysteine motifs. We have 
initially caracterized two novel AMP families, namely big defensins (about 9 KDa) featured 
by the motif C-X6-C-X3-C-X13-C-X4-C-C and hydramacin-like/ theromacin-like peptides (7-
9 KDa) with four or five disulfide bonds (Gerdol et al. 2011). Their antimicrobial character 
was confirmed by sequence analysis whereas their tissue-specific patterns of expression 
definitely persuade us to look better at the AMP expression in tissues other than 
haemocytes. 
Deep DNA/RNA sequencing is currently in progress worldwide on a variety of non-
model organisms and it is expected to provide intriguing news and additional details on 
the defensive strategies of bivalves and other marine species. 
1. Hubert et al., Eur. J. Biochem. 1996, 240 :302-6 
2. Charlet et al., J. Biol. Chem 1996, 271 :21808-13 
3. Li et al.,  ISJ 2011, 8:85-97 
4. Domeneghetti et al., ISJ, 8:179-189 
5. Rosani et al.,  PLoS One 2011,6:e26680 
6. Gerdol et al., Dev . Comp. Immunol. 2011, 35:635-45 
23)    In silico search strategies for finding new AMPs 
Davor Juretić, Damir Vukičević
a
, Nada Ilić
a
, Mario Novković
a
, Juraj Simunić
a
,               
Viktor Bojović
b
, Nédia Kamech
c
 and Alessandro Tossi
d
  (
a
Faculty of Science, University 
of Split, Split, Croatia; 
b
Ruđer Bošković Institute, Zagreb, Croatia; 
c
University Pierre 
and Marie Curie, Paris, France; 
d
University of Trieste, Trieste, Italy) 
We have developed partially or fully automated knowledge-based methods: 
a) For finding natural peptide antibiotics exhibiting promise as lead compounds (by using 
an indirect search for antimicrobial peptides associated with conserved signal 
peptides in the EST databases in combination with the therapeutic index (TI) 
prediction),  
b) For suggesting amino acid substitutions expected to decrease toxicity, increase 
selectivity and maintain antibacterial activity (the Mutator algorithm which uses the TI 
prediction),  
c) For constructing novel classes of peptide antibiotics with very little homology (less than 
50%) to any known natural or synthetic antimicrobial peptide (the Designer algorithm).  
 24 
In-silico designed peptides belong to the class of anuran-like helical peptides for which 
the TI-predictor http://split4.pmfst.hr/split/dserv1/ has been trained by using the DADP 
database http://split4.pmfst.hr/dadp/ and confirmed to work well [1-4]. 
Tests performed at the University of Trieste and at the University Pierre and Marie Curie 
(Paris) for predicted and measured TI with respect to several identified natural peptides, 
modified versions of known peptides and ab initio designed peptides have validated the 
method, with good correlation between predicted and experimental values. 
1. D. Juretić, D. Vukičević, N. Ilić, N. Antcheva, A. Tossi,  J. Chem. Inf. Model. 49, 2873-2882 (2009).  
2. D Juretić, D Vukičević, D Petrov, M Novković, V Bojović, B Lučić, N Ilić, A Tossi: Eur. Biophys. J. 40, 
371-385 (2011).  
3. V Tessera, F Guida, D Juretić, A Tossi: FEBS Journal 279, 724–736 (2012).  
4. M Novković, J Simunić, V Bojović, A Tossi, D Juretić, Bioinformatics J. (in press 2012). 
24)  Beta-defensins in the soft-shelled turtle Apalona spinifera 
L.  Dalla Valle, F. Benato, L. Alibardi (Departments of Biology, Universities of Padova 
and Bologna, Italy) 
 From a cDNA Library obtained from the skin of the soft-shelled turtle Apalone 
spinifera we have identified total or partial transcripts for 4 beta-defensins named 
TuBD1-4 containing 61-66 amino acids and with high homology, in the position of the 
6 cysteine-motif and in the N-terminus region. These peptides are expressed in the 
skin, carapace, but appear to be absent in the liver. Using a specific antibody for 
TuBD1 the only immunolabeled structures that store this peptide are represented by 
some non-specific granules localized in heterophyl granulocytes and in sparse 
granules of the epidermis. It remains unknown whether the content of the epidermal 
granules may be delivered among corneocytes of the stratum corneous that often 
contain extracellular or intracellular bacteria. 
25)  Specific conformational dynamics predefines high selectivity of lantibiotics 
to lipid II and provides opportunities for design of novel potent 
antimicrobials 
1,2
Anton Polyansky, 
2
Pavel Volynsky, 
2
Roman Efremov  (
1
Department of Structural and 
Computational Biology, Max F. Perutz  Laboratories, University of Vienna and 
2
M.M. 
Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy 
of Sciences, Moscow) 
Lantibiotics represent a class of highly specific antimicrobial peptides isolated 
from bacteria. Here we present systematic in silico study of interaction a well-known 
lantibiotic nisin A with its membrane target Lipid II. We have shown that backbone 
dynamics of the peptide is strongly constrained by a number of its modified 
aminoacids and defines selective recognition of the pyrophosphate group of Lipid II. 
Based on this we have proposed a framework for design of nisin mimics, which can 
be used in future development of novel antimicrobials. 
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26)  A novel terapeutic agent against gram-negative infections in cystic  
 fibrosis: preliminary results 
1
Antonello  Romani, 
2
F. Ghidini, 
2
S. Cavirani, 
3
M.C. Baroni and 
2
C.S. Cabassi, (
1
Surgery 
Operational Unit, University Hospital, Parma; Departments of 
2
Animal Health and  
3
Internal Medicine and Biomedical Sciences, University of Parma, Italy) 
 Cystic fibrosis(CF) leads to the production of a hyperviscous secretion 
within the airway providing a fertile ground for bacteria. The impairment of mucus-
ciliary transport and the cleaning function of the upper airway predispose for 
bacterial colonization and chronic infection by S. aureus, P. aeruginosa and other 
non-fermenting Gram-negative bacteria. These bacteria are able to acquire 
antibiotics resistance making them difficult to eradicate thus determining the 
management of patients troublesome due to inadequate therapeutic options.  A 
library of synthetic AMPs were developed and analysed by using proprietary software 
developed in house and synthesized. By using an engineered E.coli strain ML35pYC, 
one third of these peptides were able to permeabilise bacterial membrane within the 
first 30 minutes, almost two third within the first 60 minutes and the remaining 
peptides within two hours. Four randomly selected peptides were tested against 
Gram-. AMP72 was the most effective against P.aeruginosa ATCC 27853 with an LD90 
of 1.59 µg/ml, followed by AMP2041 with 4.35 µg/ml and AMP698 with 6.41µg/ml. 
The less effective was AMP2201 with an LD90 of 16.29 µg/ml. About 
Stenotrophomonas maltophilia, AMP72 was the most interesting with an LD90 of 
3.27 µg/ml, followed by AMP2041 with an LD90 of 5.2 µg/ml. The other AMPs have 
shown an LD90 equal or greater than 30 µg/ml. At 125mM salt, three out of 4 
peptides had an activity greater than 95% at 12.5 mg/ml, while at 250mM salt only 
the AMP2041 was able to kill more than 98% of cells at 12.5 µg/ml.  The products of 
this research gave the opportunity to identify novel and effective therapeutic 
approach to counteract the development, the virulence and the resistance towards 
conventional antibiotics of common and emergent bacteria involved in pulmonary 
infection in CF. 
 
 
 
 
Poster presentations 
 
1)  Synthesis of beta-defensins  
 N. Antcheva, F. Guida and A. Tossi - Department of Life Sciences, University of Trieste 
  In general the defensins are difficult to synthesise considering their length (4-5kDa), 
the presence of a hydrophobic central core and the presence of six cysteine residues. 
To overcome those problems, the synthesis of several defensins was performed on a 
Automated Microwave - Enhanced Solid Phase Peptide Synthesizer (Liberty, CEM, 
USA) using different resins and conditions. HumanhBD3, bovine LAP and the artificial 
designed defensin tBD were synthesised using preloaded TGA resins. The coupling 
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temperature was set at 75°C except for Fmoc-Cys(Trt)-OPfp ester (45°C) to prevent 
racemisation. For each coupling step a solvent mixture of DMF/DCM 80/20 was used. 
Double coupling was carried at positions predicted to be difficult. Human hBD2 has a 
C-terminal Pro, so was synthesised using 2-chlorotrityl chloride resin with low 
substitution (<0.15 meq/g). The coupling and deprotection temperatures were 
reduced to 45°C to prevent cleavage of the peptide from the acid labile trityl resin 
due to release of HCl at higher temperatures. The good quality of the crude peptides 
permitted us to fold them directly without prior purification, in freshly prepared N2-
saturated aqueous buffer pH 7,8 in the presence of the cysteine/cystine pair (20 µM 
peptide,10×Cys2, 100×Cys). The correct folding was partly confirmed by ESI-MS 
analysis of fragments obtained by enzymatic digestion (Trypsin/Chymotrypsin), [1]. 
The antimicrobial activity of the defensin was confirmed by MIC determination, while 
fluorimetric and flow cytometric assays were used to investigate the effects on 
prokaryotic cell membranes. Biophysical methods, such as circular dichroism (CD), 
transmission or reflection IR, SPR and dye release were used to probe 
structure/activity in the presence of model membranes (anionic DPPC/DPPG, 4/1 and 
neutral PC/Sm/Ch, 2/2/1 bilayers). These studies indicated that specific structural 
features modulated the efficiency of membrane insertion and selectivity for 
microbial or host-cell membranes [2]. The ability of hBD2 to bind to cellular 
membranes and internalize into host cells such as macrophages or dendritic cells was 
also studied using flow and confocal microscopy and confirmed its capacity to 
efficiently internalise into these cells without being accompanied by cytotoxic activity 
[3]. 
1.    Antcheva N, Morgera F, Creatti L, Vaccari L, Pag U, Pacor S, Shai Y, Sahl HG, Tossi A,  
 Biochem. J.  2009, 421, 435-447. 
2.   Morgera F, Antcheva N, Pacor S, Quaroni L, Berti F, Vaccari L, Tossi A, J. Pept. Sci. 2008, 14,  
 518-523. 
3.  Morgera F, Pacor S, Creatti L, Antcheva N, Vaccari L, Tossi A, Biochem J. 2011 436(3):537-46. 
2)  Biophysical properties of antimicrobial peptides and viroporins studied 
under strict physiological conditions by means of enhanced patch-clamp 
technique 
 Marco Aquila, Anna Fasoli, Giorgio Rispoli and Mascia Benedusi  -  Institute for Maternal 
and Child Health IRCCS “Burlo Garofolo”-Trieste, Italy  &  Department of Biology and Evolution, 
University of  Ferrara, Italy 
 Many short peptides selectively permeabilize the bacteria plasma membrane, 
leading to their lyses and death: they are therefore a source of antibacterial 
molecules, and inspiration for novel and more selective drugs. Another class of short 
(<100 residues) membrane proteins called viroporins, because they are coded by viral 
genes, permeabilizes the membrane of susceptible cells during infection of by most 
animal viruses. The permeabilization leads to host cell lyses and the release of the 
virus mass, replicated at host cell expense, to propagate the infection. Here, the 
patch-clamp technique is employed to study the mechanism of membrane 
permeabilization induced by the pore-forming peptides, under strict physiological 
conditions. This goal is achieved by recording the ion current through the channels 
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formed by these peptides, once inserted in the photoreceptor rod outer segment 
mechanically isolated from the retina of low vertebrates. This is the most suitable cell 
to carry on the above studies, because it was possible to fully block all its 
endogenous currents with light, without using any drug that could obstruct the 
peptide pores or interfere with the pore formation. Peptides, ions, and drugs were 
applied to (and removed from) the extracellular side in ~50 ms with a computer-
controlled microperfusion system, so that the dynamics of pore formation, and the 
pore selectivity, blockade and gating could be precisely assessed. 
  When recording large currents, it is necessary to minimize series resistance, to 
reduce time constant of charging the cell membrane capacitance and error in 
membrane potential control. A second problem arises from the plasma membrane 
asymmetry: it is conceivable that peptide permeabilization depends upon the side of 
the membrane to which it is applied. These two problems could be circumvented by 
widening the patch pipette shank, through the calibrated combination of heat and air 
pressure. These pipettes dramatically reduce series resistance, and allow at the same 
time to insert pulled quartz or plastic tubes very close to the pipette tip, making it 
possible the delivery of large molecules to the cytosol with a controlled timing. 
Finally, it is presented here a simple procedure to consistently attain seals with 
conventional or pressure polished pipettes, made from just one glass type, on a wide 
variety of cell types, isolated from different amphibian, reptilian, fish, and 
mammalian tissues, and on artificial membranes made with many different lipid 
mixtures. 
3)  Effect of pH on the interaction of the human antimicrobial peptides 
hepcidin 20 and 25 with Escherichia coli ATCC25922 and model membranes 
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 The human hepcidin 25 (hep-25) is a peptide mainly produced by the liver and 
involved in iron homeostasis. Its isoform, hepcidin 20 (hep-20) lacks the first 5 
residues at the N-terminus and has an unknown function. The hepcidins are beta-
sheet structured peptides endowed with antimicrobial activity against Gram-negative 
and Gram-positive nosocomial bacterial strains as well as the yeast Candida glabrata. 
Interestingly, we previously reported that acidic pH enhances the microbicidal effect 
of both peptides, reducing their active concentrations and shortening their killing 
times. Aim of the present study was to investigate whether pH influences the mode 
of hepcidins’ interaction with Escherichia coli ATCC 25922 and model membranes. 
Enzymatic assays on the release of β-galactosidase (a marker of membrane damage) 
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by hepcidin-treated E. coli cells, revealed a striking release of the enzyme by bacterial 
cells incubated with both peptides at pH 5.0, while no inner membrane 
permeabilization capacity was seen at pH 7.4 even at bactericidal concentrations. 
Similar results were obtained assessing, by flow cytometry, the internalization of the 
DNA intercalating-dye propidium iodide by hepcidin-treated E. coli cells. Scanning 
electron microscope imaging revealed that both peptides induced, at acidic pH, a 
more evident membrane damaging effect (evidenced as significant blebbing on the 
bacterial surface) than at neutral pH. Furthermore, colorimetric and fluorescence 
based assays performed on phospholipidic vesicles and liposomes at acidic and/or at 
neutral pH showed a slight membrane damaging effect at pH 7.4, while at acidic pH a 
more dramatic effect on vesicle integrity was observed. A DNA retardation migration 
test, performed at pH 7.4, revealed that both hepcidins bind plasmidic DNA at high 
affinity suggesting an intracellular targeting mode of action at neutral pH.  
  On the whole, the above reported data suggest that hepcidins’ ability to perturb 
bacterial membranes is pH-dependent. Since both physiological and pathological 
conditions are responsible for generating a low pH in vivo, it is tempting to speculate 
that the enhancing effect of pH on bactericidal activity of human hepcidins may 
represent a mechanism to promptly control bacterial invasion in cellular 
compartments or body districts characterized by acidic pH. 
 
4)  Biophysical characteristics and pore formation dynamics of cecropin-
melittin hybrid peptide (cm15) in a natural membrane 
 Anna Fasoli, Marco Aquila, Giorgio Rispoli and Mascia Benedusi - Department of Biology 
and Evolution, University of  Ferrara, Italy 
 The mechanism of membrane permeabilization of the synthetic cecropin-melittin 
hybrid peptide (Acetyl-KWKLFKKIGAVLKVL-CONH2; CM15) is still unclear. This 
mechanism was investigated by using a novel technique, consisting in the insertion of 
CM15 peptide in the plasma membrane of an isolated photoreceptor rod outer 
segment (OS) of vertebrate retina, which is the solely cell system in nature possessing 
just one channel type, that can be fully closed by light. Therefore, the ionic current 
recorded in whole-cell, voltage-clamp configuration from an OS at a given potential 
(Vh), is flowing entirely through the exogenous pores formed by the peptide channels, 
if the OS is illuminated. CM15 was rapidly applied (and removed) to (from) the OS in 
~50 ms with a computer-controlled microperfusion system, in order to measure the 
dynamics of pore formation (and disaggregation). Once the main OS endogenous 
conductance was blocked with light, the OS membrane resistance was ≥1 GΩ, 
allowing high resolution, low-noise recordings. It was found that CM15 produced 
voltage-independent membrane permeabilization, repetitive peptide application 
caused a progressive permeabilization increase, and no single-channel events were 
detected at low peptide concentrations. Collectively, these results indicate a toroidal 
mechanism of pore formation by CM15. 
Keywords: peptide antibiotics; photoreceptors; ion channels; patch-clamp. 
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5)  Studying glycopeptide antibiotics and their producers in the fight against 
multi-resistant bacteria 
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 Glycopeptide antibiotics are produced by filamentous actinomycetes and inhibit 
the synthesis of bacterial cell wall by blocking peptidoglycan assembly. They bind to 
the D-alanyl-D-alanine (D-Ala-D-Ala) C terminus of the nascent peptidoglycan and 
prevent it from being utilized in the following cross-linking reactions catalyzed by 
transglycosylases and transpeptidases. The structurally related glycopeptides 
vancomycin and teicoplanin have been introduced in clinical settings since 1958 and 
1988, respectively. These drugs are still extensively used against multi-resistant 
enterococci and methicillin-resistant staphylococci. Concern about vancomycin-
resistant enterococci has been increasing during the last decade, and highly 
vancomycin resistant Staphylococcus aureus isolates have recently appeared in 
clinical specimens. In glycopeptide resistant bacteria, reorganization of the cell wall is 
directed by the expression of van gene clusters. Identification of van gene 
homologous in the genomes of several glycopeptide-producing actinomycetes 
suggests the involvement of a similar self-resistance mechanism to avoid suicide 
during production phase. Our research is focalized on two glycopeptide producing 
actinomycetes: Nonomuraea sp. ATCC 39727, which produces A40926 – the 
precursor of the second generation glycopeptide dalbavancin –, and the teicoplanin 
producer Actinoplanes teichomyceticus ATCC 31121. Part of our work is devoted to 
the optimization of fermentation process to increase the production of these 
glycopeptides according to pharmacopeia standards. We are also developing tools 
for the genetic manipulation of these actinomycetes to improve their antibiotic 
production. Our studies show that in A. teichomyceticus vanHAX genes are 
constitutively expressed to confer a high level of glycopeptide resistance, whereas in 
Nonomuraea sp. a moderate level of self-resistance is due to the activity of a D,D-
carboxypeptidase encoded by vanY gene. The link between glycopeptide resistance 
and production in these actinomycetes is currently under investigation. 
6)  Membrane thickness and the mechanism of action of the short peptaibol  
     trichogin GA IV 
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 Trichogin GA IV (Tric) is an antimicrobial peptide belonging to the peptaibol 
family, the most studied member of which is alamethicin (Alm). It acts by perturbing 
membrane permeability. Previous data showed that pore formation is linked to Tric 
aggregation and insertion in the hydrophobic core of the membrane [1-3]. This 
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behaviour is similar to that of Alm and is in agreement with a barrel-stave mechanism 
in which transmembrane oriented peptides aggregate to form a channel. However, 
while the 19-residue Alm has a length comparable to the membrane thickness, Tric is 
just 10-residue long. Therefore, its helix is about half the bilayer thickness. Molecular 
dynamics simulations predicted that in its transmembrane orientation Tric interacts 
strongly with the polar phospholipid headgroups, drawing them towards its N- and C-
termini. Thus, using this mechanism Tric might be able to span the entire bilayer. 
Indeed, neutron reflectivity measurements on a POPC bilayer and a deuterated Tric 
analog indicated that the peptide inserts in the hydrophobic region of the membrane 
causing a significant thinning (from about 30 Å to 20 Å). Finally, vesicle leakage 
experiments demonstrated that Tric activity is significantly higher with thinner 
membranes, becoming similar to that of Alm when the bilayer thickness is 
comparable to its size. Overall, these data indicate that a barrel-stave mechanism of 
pore formation might be possible for Tric despite its relatively small size. 
 1. Stella, L.; Mazzuca, C.; Venanzi, M.; Palleschi, A.; Didonè, M.; Formaggio, F.; Toniolo, C.; 
Pispisa, B. Biophys. J. 2004, 86, 936-945. 
 2. Mazzuca, C.; Stella, L.; Venanzi, M.; Formaggio, F.; Toniolo, C.; Pispisa, B. Biophys. J. 2005, 88, 
3411-3421. 
 3. Salnikov, E.S.; Erilov, D.A.; Milov, A.D.; Tsvetkov, Yu.D.; Peggion, C.; Formaggio, F.; Toniolo, C.; 
Raap, J.; Dzuba, S.A. Biophys. J. 2006, 91, 1532-1540. 
 
7)  “Minimum bias” molecular dynamics simulations to determine peptide 
orientation in membranes  
 G. Bocchinfuso, A. Farrotti, A. Palleschi, B. Bechinger, L. Stella  - Department of Chemical 
Science and Technology, University of Rome Tor Vergata 
 The development of more effective antimicrobial peptides (AMPs), to fight drug-
resistant bacteria, requires a detailed understanding of their mechanism of 
membrane perturbation, and of their position and orientation inside lipid bilayers. 
Molecular dynamics simulations can predict such information, but the simulation 
time-scales are often too short for a peptide to attain its most stable position in a 
preformed membrane. To overcome this limitation, the so-called “minimum-bias” 
approach was developed [1,2] in which the simulation starts from a random mixture 
of lipids, water and a peptide molecule, and a bilayer self-assembles during the 
trajectory. The high fluidity of the system during this process ensures that the 
peptide can find its minimum free energy configuration in the final membrane. In this 
work we provide a very stringent test of the reliability of this approach, by using the 
artificial AMP LAH4, which contains no cationic amino acids, but comprises four His 
residues, which change their protonation state with pH. Solid-state NMR experiments 
demonstrated that at acidic pH values this peptide is always located on the 
membrane surface, while at pH where the His residues are neutral the peptide 
inserts in a transmembrane orientation [3]. Several independent simulations were 
performed for both the charged and neutral peptide state (for a cumulative 
trajectory length of almost 2 μs). In all cases the charged LAH4 remained in contact 
with the phospholipid headgroups, while in the neutral state it became embedded in 
the acyl tails, in agreement with the experimental data. These simulations provide 
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the possibility to analyze how peptide orientation and charge influence its 
membrane-perturbing properties. 
1.  Esteban-Martìn, S.; Salgado, S. Biophys. J. 2007, 92, 903-912. 
2.  Bocchinfuso, G.; Palleschi, A.; Orioni, B.; Grande, G.; Formaggio, F. Toniolo, C.; Park, Y.; Hahm,  
     K.S.; Stella, L. J. Pept. Sci. 2009, 15, 550-558. 
3.  Georgescu, J.; Munhos, V.H.; Bechinger, B. Biophys. J. 2010, 99, 2507-2515. 
8)     Development, characterization and antimicrobial activities of new cationic 
peptides with a wide activity  spectrum 
 1Clotilde Silvia Cabassi, 2Tullia Tedeschi, 1Sandro Cavirani, 3Maria Cristina Baroni and 
3
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 The therapeutic approach to infection was changed by using antimicrobial drugs. 
The need for new and even more effective antimicrobial compounds induced 
pharmaceutical companies to develop novel drugs resulting an armoury of over two 
hundreds different molecules. However, the developing of drug-resistance to 
antibiotic compounds is nowadays faster than the discovery of novel classes of 
antimicrobial drugs. This has forced since 2003 the halting of any efforts to discover 
novel molecules by pharmaceutical companies. 
 A potential answer to overcome the antibiotic-resistance is represented by a 
wide-spectrum novel cyclic antimicrobial peptides (AMPs) recently developed by our 
research group. These AMPs are characterized by a length ranging from 10 to 30 
aminoacid residues and random coil conformation in aqueous solvent. The cyclization 
was obtained by introducing several cycteines in different positions of sequences. 
The optimal percentage of hydrophobic aminoacidic residues assures the lacking of 
eukaryotic membrane perturbation. Moreover, the hydrophobic clustering along 
three-dimensional structure confer a high salt-tolerance. Finally, they show high 
solubility, low, if any, hemo-and cyto-toxicity. 
 The antimicrobial activity against Gram-negative bacteria such as Escherichia coli 
ATCC 25922, Pseudomonas aeruginosa e Stenotrophomonas maltophilia indicated 
E.coli LD90  ranging from 0.83 uM (1.5 ug/ml) e  10.64 uM (19.63 ug/ml) while for  P. 
aeruginosa tra 0.87 uM (1.59 ug/ml) e 7.68 uM (16.29 ug/ml). Then the LD90 
obtained with Stenotrophomonas maltophilia ranging between 1.88 uM (3.42 ug/ml) 
and 2.67 uM. Interesting are, moreover, the results obtained  against Gram-positive 
bacteria and in particular against MRSA. Two tested peptides showed a LD90 
between 0.85 uM (1.65 ug/ml) and 0.90 uM (1.72 ug/ml). Similarly, using S.aureus 
methicillin-sensitive the LD90 were from 1.42 uM (2.89 ug/ml) and 13.4 uM (28.77 
ug/ml). The AMPs developed were also active against fungi and yeast such as Candida 
albicans. The LD90 ranged from 0.68 uM (1.24 ug/ml) to 39 uM (circa 70 ug/ml). 
 In conclusion, such peptides can be effectively used as primary agents or 
adjuvants in the treatment of infectious diseases of human and animals 
 
 32 
9) Antimicrobial lipopeptaibiotic trichogin GA IV: role of Aib to L-Leu 
substitutions on conformation and bioactivity 
 Barbara Biondi, Marta De Zotti, Yoonkyung Park, Kyung-Soo Hahm, Claudio Toniolo, 
Fernando Formaggio, and Marco Crisma - Institute of Biomolecular Chemistry, 
Padova Unit, CNR 
 The lipopeptaibiotic trichogin GA IV is a natural, non-ribosomally synthesized, 
antimicrobial peptide remarkably resistant to the action of hydrolytic enzymes. This 
feature may be connected to the multiple presence in its sequence of the noncoded 
residue α-aminoisobutyric acid (Aib), which is known to be responsible for the 
adoption of particularly stable helical structures already at the level of short peptides. 
To investigate the role of Aib residues on the 3D-structure and bioactivity of trichogin 
GA IV, we synthesized and fully characterized four analogs where one or two Aib 
residues are replaced by L-Leu. Our extensive conformational studies (including an X-
ray diffraction analysis) and biological assays performed on these analogs showed 
that the Aib to L-Leu replacements do not significantly affect the resistance to 
proteolysis, but modulate the bioactivity of trichogin GA IV in a 3D-structure related 
manner 
10)  Analysis of Defb1 regulatory SNPs in cystic fibrosis patients from north 
eastern Italy  
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 In our study we analyzed the three 5’ UTR regulatory DEFB1 SNPs -52 (G/A), -44 
(C/G) and -20 (G/A) in a group of cystic fibrosis patients from North Eastern Italy, and 
in healthy controls, with the aim of verifying the possible involvement of these 
functional SNPs in CF pathogenesis. 
Genotypes and alleles frequencies of the -44 (C/G) and -20 (G/A) SNPs were similar in 
CF patients and healthy controls and no significant difference was evidenced 
between the two analyzed groups.  
 Conversely, a difference in the distribution of the -52 (G/A) SNP genotypes was 
evidenced when comparing CF patients and healthy controls (p=0.0081): DEFB1 -52 
GG genotype was more frequent in CF patients (0.52) than in healthy controls (0.30). 
11)  Modulation of cytokine gene expression by cathelicidin BMAP-28 in LPS-
stimulated and -unstimulated macrophages 
 Francesca D’Este, Linda Tomasinsig, Barbara Skerlavaj and Margherita Zanetti - 
Department of Medical and Biological Sciences, University of Udine. 
 Apart from direct bacterial killing, antimicrobial host defence peptides (HDPs) 
exert various other biological activities that also include modulation of immune 
responses to infection. The bovine cathelicidin BMAP-28 has been extensively studied 
with regard to its direct antibacterial activity while little is known about its effects on 
immune cell function. We have investigated its ability to affect inflammatory 
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pathways and to influence the proinflammatory response induced by LPS in RAW 
264.7 macrophages, in terms of modulation of TLR4 activation and cytokine gene 
induction. BMAP-28 on its own elicited ERK1/2, p38 and NF-κB activation leading to 
upregulation of IL-1β gene expression in these cells, suggesting it has the capacity to 
activate selected cellular pathways through direct effects on macrophages. As 
expected based on its in vitro LPS-binding properties, BMAP-28 blocked LPS-induced 
cytokine gene expression when added to the cell culture in combination with LPS. 
However it enhanced the induction of IL-1β and IL-6 genes and suppressed that of 
IFN-β when added prior to or following LPS stimulation over a 30-60 min time interval, 
or when co-administered with taxol as another TLR4 stimulant. It did not inhibit the 
expression of IFN-β induced by the TLR3 ligand poly(I:C). Overall these results, and 
the fact that BMAP-28 increased the LPS-stimulated activation of NF-κB while 
diminishing that of IRF-3, suggest that the peptide potentiates the early TLR4–
mediated proinflammatory cytokine response while inhibiting the TLR4/TRAM/TRIF 
signalling pathway leading to IRF-3 activation and IFN-β gene expression. Using a 
TLR4-specific antibody we also found that BMAP-28 decreased the LPS-induced 
internalization of surface TLR4 required for initiating the TRAM/TRIF signalling 
pathway, which provides a mechanism for the inhibitory effect of the peptide on the 
TLR4/TRAM/TRIF pathway. 
12) Antimicrobial Peptides from food sources  
 C. De Gobba, J. H. Otte - Department of Food Science, University of Copenhagen 
 Food proteins can be processed into peptides with desirable activities against 
important diseases, such as cardiovascular diseases, diabetes and cancer. Peptides 
derived from milk or fish proteins are known to inhibit angiotensin converting 
enzyme (ACE) involved in blood pressure regulation, affect immune defence, inhibit 
microbial activity, and have antioxidative as well as antiproliferative activities on 
human breast cancer cell lines.  
 The release of high-value health-promoting peptides from larger food proteins is 
performed by means of proteolytic enzymes. The commonly used proteolytic 
enzymes such as trypsin and lactic acid bacteria enzymes are most active around 35-
40 °C and normal atmospheric pressure, so all processes based on these enzymes 
may give rise to hygiene or organolepsis problems. Therefore, the aim of the multi-
partner collaborative project NOVENIA is to find novel enzymes for industrial use; we 
will use novel cold-active proteolytic enzymes from psychrophilic microorganisms 
and pressure-stable proteolytic enzymes from barophilic bacteria in cold processes to 
produce bioactive peptides from protein sources like milk and fish.  
The purpose of our part of the project is to set up screening assays to detect 
bioactive peptides in hydrolysates made by the action of the novel enzymes on food 
proteins. 
 This poster will present the results from the screening for antimicrobial peptides 
using hydrolysates of bovine milk casein proteins. These hydrolysates are prepared 
using enzymes taken from the supernatant of a culture of the bacterium 
Arsukibacterium ikkense, the commercial enzyme papain and a novel enzyme from 
the carnivorous plant Dionaea muscipulan (Venus flytrap). 
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13) Characterization of the salmonid cathelicidins and of their biological 
activities. 
Michela Furlan, Giuseppe Cannone, Monica Benincasa, Alberto Pallavicini, Renato 
Gennaro, Marco Scocchi - University of Trieste, Dept. of Life Sciences, Trieste, Italy 
 Cathelicidins are a family of cationic antimicrobial peptides (AMPs) and an 
important component of the innate immune responses. Members of this family have 
recently been identified in salmonids and other fishes. The analysis of the Cath-1 and 
Cath-2 salmonid cathelicidin sequences evidenced an organization with a conserved 
cathelin domain and a relatively long and varied glycine/serine-rich C-termini domain. 
 In this study we characterized the antimicrobial activity spectrum, the mode of 
action and tissue localization of some of the C-termini peptides of salmonid 
cathelicidins. Different peptide fragments representing specific regions of CATH1 
and/or CATH2 of rainbow trout (Oncorhynchus mykiss), brook trout (Salvelinus 
fontinalis), grayling (Thymallus thymallus) and brown trout (Salmo trutta fario) have 
been chemically synthesized and their antimicrobial activity evaluated against 
standard bacterial strains and some fish pathogens. Most peptides showed a 
medium-dependent antimicrobial activity with MIC values ranging from 4 µM to 64 
µM. Killing kinetics and membrane permeabilization assays indicated that these 
peptides rapidly kill their bacteria targets by permeation of the cell membranes. 
Hemolytic assay on peripheral human blood evidenced a very low toxicity against 
eukaryotic cells. To identify CATH-1 in trout tissues and to study its processing, a 
recombinant CATH-1 derived from O. mykiss spleen cDNA has been expressed in E. 
coli and purified as a glutathione S-transferase fused form. Western blot analysis, 
performed with a polyclonal antibody raised against the whole protein by using the 
recombinant CATH-1 as an antigen, revealed that the protein is abundantly expressed 
in spleen and head kidney tissues and it is detected as multiple forms of different 
MW. Experiments are ongoing to determine eventual CATH-1 posttrasductional 
modifications as well its tissue distribution. Results will contribute to a comparative 
understanding of the functions of cathelicidins in the vertebrates. 
14) Antimicrobial photodynamic therapy: synthesis, conformational properties 
and antibacterial activity of peptide-porphyrin conjugates  
 V. Sella, E. Frezza, R. Dosselli, E. Reddi, A. Ferrarini, M. Gobbo - Department of Chemical 
Science, Univeristy of Padova 
 The worldwide rise of antibiotic resistance stimulates the search for new 
strategies for controlling bacterial infections based on the use of agents different 
from the common antibiotics. Two promising approaches are the application of 
photodynamic therapy (PDT) and of cationic antimicrobial peptides (CAMP) in the 
treatment of localized infection.  
 PDT involves the use of non-toxic dyes or photosensitizers (PS), that can generate 
reactive oxygen species upon exposure to light in the presence of oxygen. It is well 
establish that singlet oxygen is produced as the main species responsible for cell 
death.  
 CAMP are components of the innate defense mechanism of many organisms. 
They are short peptides (10-50 amino acids), with an overall positive charge 
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(generally +2 to +9) and a substantial proportion (≥30%) of hydrophobic residues. 
These properties permit the peptide to fold into an amphipathic structure, often 
upon contact with membranes, and ensures accumulation at the poly-anionic 
microbial cell surfaces.  
 In general neutral, anionic or cationic PS molecules can efficiently kill Gram-
positive bacteria, whereas Gram-negative bacteria are less susceptible to 
phodynamic killing and only cationic porphyrins can induce their photo-inactivation. 
On the contrary CAMP exhibit a broad spectrum of antimicrobial activity and do not 
easily induced resistance compared to conventional antibiotics. Thus the use of 
CAMP in combination with PDT is expected to enhance the effectiveness of PDT. 
 Recently we have shown that the conjugation of apidaecin 1b, a 18-residue 
peptide, to a 5(4’-carboxyphenyl)-10,15,20-triphenylporphyrin (cTPP) photosensitizer 
afforded a new antibacterial agent, with a broader spectrum activity with respect to 
that of the two individual components or a mixture of them [Rosselli R et al ACS Med. 
Chem. Lett. (2010) 1, 35].  
 Here, we present the synthesis of a new conjugate between cTPP and the 
membrane active peptide magainin 2 and a preliminary investigation of its 
antibacterial activity, in the dark and under light-activation. Moreover, the 
conformational properties of the porphyrin-peptide conjugates will be compared to 
those of the parent peptides and an interpretation of the circular dichroism spectra 
with respect to the assembling of these systems in aqueous environment will be 
presented. 
15)  Features of the primary structure of the PR-AMP Bac7 important for its 
internalization capacity and antimicrobial activity. 
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The proline-rich peptides are a group of linear AMPs, isolated from both 
mammals and invertebrates, active mainly against Gram-negative bacteria, which act 
intracellularly being internalized without an apparent damage to bacterial 
membranes.  
The sequence of the bovine cathelicidin Bac7, a reference Pro-rich AMP (PRAMP) 
has been subjected to several studies identifying the N-terminal region as responsible 
for the antimicrobial activity. To search for the minimal entry sequence into bacteria, 
and to investigate whether this overlaps with the minimal antimicrobial fragment, a 
set of progressively shortened labelled N-terminal fragments of Bac7 were 
synthesized and tested for their antibacterial activity and internalization capacity into 
E. coli cells by flow cytometry and confocal microscopy. While N-terminal fragments 
as short as 16 residues were both fully active and efficiently internalized into the cells, 
further shortening significantly reduced both these functions.  
In addition the role of the two key N-terminal Arg residues of Bac7 on 
penetration of the outer membrane and translocation through a putative inner 
membrane transporter was probed by systematically substituting with lysine, D-Arg, 
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nitro-Arg [4], dimethyl-Arg [4], peptoid Arg and citrulline, or by omitting them and by 
using mutants of E.coli strains with deleted transport system or altered outer 
membrane characteristics. 
The results indicated that stereochemistry, charge and H-bonding all seem to be 
important requirements for the activity and internalization of this PR AMP. These are 
relevant to both outer membrane transit and the translocating role of inner 
membrane transporter, which was confirmed. These studies have helped evaluate 
Bac7 as a potential anti-infective agent selective for Gram-negative bacteria, as well 
as a possible vehicle for internalization of antibiotic cargo into these, and suggested 
unnatural variants with potentially improved activity. 
 
16)   Cell wall biosynthesis in cell wall-less endobacteria - new options for  
 antibiotic treatment? 
A. Gaballah
a
, A. Kloeckner
a
, C. Otten, H. Buehl
a
, S. De Benedetti
a
, T. Schneider
a
, H.G. 
Sahl
a
, B. Henrichfreis,
a,b
 - aInstitute of Microbiology and Biotechnology, University of Bonnand 
b Novozymes A/S,  NAM Project members  
Searching for new antibacterial targets in chlamydiae we focus on co-ordination 
of cell wall biosynthesis and cell division, two essential processes driven by partially 
overlapping multi-protein machineries whose activity needs to be tightly controlled 
to maintain cell integrity. Previously, we discussed that maintaining biosynthesis of 
the completed cell wall building block, lipid II, in cell wall-lacking endobacteria like 
chlamydiae may reflect a vital role of lipid II biosynthesis in prokaryotic cell division.  
Currently, we investigate orchestration and regulation of chlamydial lipid II 
biosynthesis and cell division in vitro. We analyze how the chlamydial actin ortholog 
MreB is functionally organizing lipid II biosynthesis and demonstrate increased 
transferase activity of the cell wall enzyme MraY in the presence of MreB. In addition, 
we investigate whether elongation factor EF-Tu serves as a cytoskeletal component 
in chlamydiae as shown before for the orthologous protein in Bacillus. EF-Tu interacts 
with MreB and both proteins mutually increase their polymerization. Moreover, we 
study the regulatory function of eukaryote-like Ser/Thr kinases and phosphatases and 
prove that biosynthesis of cell wall precursors is affected by kinase PknD and that 
phosphatase Cpn0397 exhibits dephosphorylation activity.  Deeper insight in co-
ordination and regulation of lipid II biosynthesis and cell division will provide a basis 
for the design of new drugs to combat diseases caused by chlamydiae and other 
bacterial pathogens. 
 
17)    The interaction of nep1-like proteins with lipids 
 Vesna Hodnik
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  The family of necrosis- and ethylene-inducing peptide 1 (NEP1)-like proteins 
(NLPs) elicit diverse defense reactions and cell death in dicotyledonous plants. They 
are cytolytic proteins, structurally similar to actinoporins, pore forming toxins from 
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marine invertebrates. A membrane disrupting activity was demonstrated for NLPs [1]. 
The other proteins that have similar structure are fungal lectins. All these proteins 
interact with specific structures at the membranes surface; actinoporins with 
sphingomyelin and lectins with carbohydrates. When plasma membranes were 
pretreated with different proteases and glycosidases the NLP proteins still bound to 
the membranes, therefore, the target molecule on the host cell is most probably of 
lipid origin. We have used multilamellar vesicles prepared from lipid extract from 
tobacco leaves in a binding assay for different NLPs (NLPPp from Phytophthora 
parasitica, NLPPcc from Pectobacterium carotovorum subsp. carotovorum and 
NLPPya from Pythium aphanidermatum). The secondary structure of proteins at 
different pH values was evaluated by using circular dichroism. Crystal structure of 
NLPPya reveals a single-domain molecule with a fold consisting of a central β-
sandwich, with 3 strands in the first sheet and a 5-stranded antiparallel second sheet. 
Three helices encompass the second sheet at the top of the sandwich. At the base of 
the protein an uneven surface is established mainly by 3 broad loops [1]. We evaluate 
stability of the protein in different buffers using circular dichroism (CD) and 
differential scanning fluorimetry (DSF). According to the far UV circular dichroism 
spectra the proteins do not undergo structural changes upon pH change from 7.4 to 
5.5. When comparing the near UV circular dichroism spectra we observed changes 
when lowering pH to 5.5 in the range where phenylalanine has a characteristic profile. 
DSF revealed that NLPPp is most stable at pH 6.0 and is more stable when disulfide 
bonds are preserved. The binding of proteins to small unilamellar vesicles from lipids 
extracted from plasma membranes from Arabidopsis thaliana and Commelina 
communis was evaluated using surface plasmon resonance. 
18)   Adepantins, computationally designed, glycine-rich peptide antibiotics, 
with low toxicity and very high G- selectivity 
  Nada Ilić
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 Adepantins (ADPs) are glycine-rich antimicrobial peptides (AMPs), constructed 
using the “Designer” algorithm, which is based on known characteristics of anuran 
AMPs [1]. Parameters used to predict the primary structure of ADPs include various 
physicochemical properties, such as lengthwise asymmetry and predicted 
therapeutic index (TI). ADP1 was previously tested and has shown high antimicrobial 
activity (MIC) against E. coli (2-4 µM) and low cytotoxic activity (HC50) against human 
red blood cells (480 µM). To confirm the high selectivity of peptides from this group, 
additional tests were performed for monomeric, dimeric and fluorescently labelled 
versions of ADP2 and ADP3, using different bacterial strains, host cells and model 
membrane systems. They are selective for Gram-negative bacterial cells (MIC = 0.5 - 
4 µM) both with respect to human erythrocytes (HC50 > 400 µM for monomers), as 
with ADP1, and with respect to Gram-positive bacteria (MIC > 128 µM). Dimers have 
high haemolicity and exceptional antimicrobial activity. All adepantins structure as 
alpha helices when in contact with PG/dPG liposomes, while maintaining a random 
coil structure in the presence of PC/SM/Ch membranes. At sub-toxic concentrations, 
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dimers exhibit much higher permeabilization of both bacterial membranes in various 
E. coli strains than monomers. The “Designer” algorithm thus identified novel AMPs 
less than 50% homologous to any other natural or synthetic AMP, highly selective for 
Gram-negative bacteria and with a high TI (up to 400). 
[1] D. Juretić, D. Vukičević, N. Ilić, N. Antcheva, A. Tossi, Computational design of highly selective 
antimicrobial peptides, J Chem Inf Model. 2009 Dec; 49(12):2873-2882. 
19)   Synthesis and efficiency evaluation of RND type efflux pump inhibitors  
 S. Lengvinaite, R. Daugelavicius - Department of Biochemistry and Biotechnologies, Vytautas 
Magnus University, Kaunas, Lithuania   
  Salmonella enterica serovar Typhimurium is the main cause of food poisoning and 
is the second most common cause of bacterial diarrhea [1-2]. RND-type multidrug 
resistance efflux pumps are the main reason of Salmonella enterica cell resistance to 
antibiotics. It is important to investigate the mechanism of efflux pump inhibition. 
The aim of our work was to synthesize small dipeptide inhibitors and to evaluate the 
efficiency RND-type efflux pump inhibition in S. enterica cells.  In this work we 
present data on the electrochemical assay of accumulation of an indicator compound 
of efflux pumps in bacteria tetraphenylphosphonium (TPP⁺) ions. We studied effects 
of the synthesized RND-type efflux pump inhibitors on accumulation of TPP⁺ ions in S. 
enterica. Data on the effective concentrations of the inhibitors and the efficiency of 
inhibition of RND-type efflux pump activity will be presented.  
1. Coldham, N. G., Woodward M. J. Characterization of the Salmonella typhimurium proteome 
by semi-automated HPLC-mass spectrometry: detection of proteins implicated in multiple 
antibiotic resistance. J. Proteome Res. 2004, 3, p. 595-603.  
2. Herikstad, H., Y. Motarjemi, Tauxe R. V. Salmonella surveillance: a global survey of public 
health serotyping. Epidemiol. Infect. 2002. 129, p. 1-8 
20)  The effect of D-amino acids in the target cell selectivity of the frog skin 
peptide temporin L 
 Vincenzo Luca, Paolo Grieco, Alfonso Carotenuto, Luigia Auriemma, Maria Rosaria 
Saviello, Pietro Campiglia, Ludovica Marcellini, Maria Luisa Mangoni - Department of 
Biochemical Science, University of Rome La Sapienza 
  Temporin L (TL, 13-residues long) is a frog-skin peptide with a wide and potent 
spectrum of antimicrobial activity, but with a toxic effect on mammalian cells at its 
microbicidal concentration. Previous studies indicated [Pro3]TL as an analog with a 
slightly lower hemolytic activity than the native TL. Here, a systematic replacement of 
single residues within the alpha-helix domain of Pro3 TL (Lys7 to Leu13) with D 
aminoacids, known as helix breakers, has been carried out. Structure-activity 
relationship studies, by means of CD/NMR spectroscopy analysis and 
antimicrobial/hemolytic assays have been performed leading to a better 
understanding on the structural elements that are responsible for the cell selectivity 
of TL. Most importantly, we have found how a single L-to D aminoacid substitution 
can preserve the strong anti-candida activity of [Pro3]TL, making it completely 
harmless towards human cells. 
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21) Reduced phospohorylation of LPS decreases E. coli susceptibility to the 
human cathelicidin LL-37.  
 M. Mardirossian, K. Bociek, S. Ferluga, M. Benincasa, M. Scocchi and R. Gennaro - 
Department of Life Sciences, University of Trieste, Italy  
  The human cathelicidin LL-37 is an α-helical, cationic antimicrobial peptide (AMP) 
showing both direct antibacterial activity and multifunctional immunomodulatory 
capacities. Like many other AMPs, this peptide kills bacteria primarily by altering 
membrane integrity, even thought its exact mechanism of action is still undefined. To 
increase our knowledge on the bacterial component involved in the mode of action 
of LL-37, we screened an E. coli knock-out mutant library in search for mutations 
conferring altered susceptibility to this peptide. As first, a library was created by 
random insertion of the Tn5 transposon into the bacterial genome. Secondary, 
mutants with decreased susceptibility to LL-37 were selected by plating E. coli cells of 
the bank on peptide-supplemented solid medium. The different susceptibility among 
the wild-type and mutant cells was assessed by measuring the effect of the peptide 
on the kinetics of bacterial growth, on the kinetics of bacterial killing, and evaluating, 
using flow citometry, the LL-37’s binding to bacteria and its effect on their integrity.  
  In 15 out of 20 LL-37-resistant mutants, the Tn5 trasposon was found to be 
inserted into the waaY gene, which encodes for a specific kinase responsible of the 
phosphorylation of the Hep II residue in the core region of bacterial 
lipopolysaccharide (LPS). This modification decreased the peptide’s ability to kill 
bacterial cells, correlating with a reduced binding to bacteria and with a decreased 
membrane permeabilisation. Susceptibility of these mutants to several other AMPs 
of different structural classes was however unaffected, suggesting a specific and 
selective link between the gene waaY and the mechanism of action of LL-37. 
Summarising, waaY inactivation determines a decreased antibacterial activity. The 
results reveal a putative LPS-binding site for LL-37 and stress the importance of the 
electrostatic interactions between bacterial surface and antimicrobial peptides. 
22)  DADP: the Database of Anuran Defense Peptides 
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Anuran tissues, and especially skin, are a rich source of bioactive peptides and 
their precursors. As potential antibiotics, host defense peptides from amphibian 
species are a fast growing group in the UniProtKB database. We here present a 
manually curated database (http://split4.pmfst.hr/dadp/) of antimicrobial and other 
defense peptides with a total of 2571 entries, 1766 full precursors with demarcated 
signal peptide (SP), acidic proregion(s) and bioactive moiety(s) and 805 bioactive 
defense peptides, encompassing a total of 167 anuran species from 12 families [1]. 
Each DADP entry ID contains detailed information about peptide names and 
sequences, tripartite structure, taxonomy, biogeography data (ecozone and 
distribution), SP class, tissue, biological function, links to UniProtKB, references and 
activity data in the form of minimal inhibitory concentration (MIC, µM) for E. coli 
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and/or S. aureus and concentration required for 50% haemolysis of red blood cells 
(HC50). Precursor structure is informative about origin, function and evolution of 
anuran host defense peptides, while more than 900 mature peptides with known 
MIC values in DADP are a valuable resource for structure-activity studies. The DADP 
focus on precursors and their conserved SPs has allowed the individuation of six 
distinct SP classes. The more conserved of these can be used for searching cDNA, 
UniProtKB or other protein databases for novel bioactive peptides, for creating 
PROSITE search patterns, and for phylogenetic analysis. 
 [1] M. Novković, J. Simunić, V. Bojović, A. Tossi and D. Juretić, DADP: the Database of Anuran 
Defense Peptides, Bioinformatics J., (in press 2012). 
 
23)  Cyclic lipopeptides: design, synthesis and antimicrobial activity  
Sílvia Vilà, Cristina Orozco, Esther Badosa, Emilio Montesinos, Lidia Feliu and Marta 
Planas - LIPPSO,  University of Girona, Spain 
 Antimicrobial peptides are secondary metabolites isolated from a wide range of 
organisms and have been shown to be effective against plant pathogenic bacteria 
and fungi. These peptides are considered a good alternative to traditional antibiotics 
for plant disease control. Among antimicrobial peptides, cyclolipopeptides, such as 
surfactins, fengycins or iturins, are produced by several plant-associated and soil-
inhibiting bacteria, and display antifungal, antibacterial, and cytotoxic activities. For 
these compounds, it has been observed that the presence of a hydrophobic tail in 
their structure favours their insertion into the cytoplasmatic membrane and, 
therefore, improves their activity. 
 Recently, we have identified antimicrobial peptides active against the 
phytopathogenic bacteria and fungi. In particular, de novo designed cyclic peptides, 
with the general structure cyclo(X3–Phe–X5–Gln) where X = Lys or Leu, have been 
prepared and screened for their biological activity. The most active peptide was 
c(KKLKKFKKLQ) (BPC194) which also displayed low hemolysis. With the aim of 
improving the biological activity of BPC194, in this work, this cyclic peptide was 
derivatized with different fatty acids. For this purpose, one or two lysine residues 
present in the sequence were acylated. The resulting cyclolipopeptides were 
evaluated in vitro against phytopathogenic bacterial and fungal strains, and assayed 
for their hemolytic activity. 
24)  Specific conformational dynamics predefines high selectivity of lantibiotics 
to lipid II and provides opportunities for design of novel potent 
antimicrobials  
 Anton Polyansky, Pavel Volynsky, Roman Efremov  - Department of Structural and 
Computational Biology, Max F. Perutz  Laboratories, University of Vienna & M.M. Shemyakin 
and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 
 Lantibiotics represent a class of highly specific antimicrobial peptides isolated 
from bacteria. Here we present systematic in silico study of interaction a well-known 
lantibiotic nisin A with its membrane target Lipid II. We have shown that backbone 
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dynamics of the peptide is strongly constrained by a number of its modified 
aminoacids and defines selective recognition of the pyrophosphate group of Lipid II. 
Based on this we have proposed a framework for design of nisin mimics, which can 
be used in future development of novel antimicrobials.   
25) A novel dendrimeric peptide with antimicrobial properties: structure-
function analysis of SB056 
Scorciapino MA, Pirri G, Vargiu AV, Ruggerone P, Giuliani A, Casu M, Buerck J, 
Wadhwani P, Ulrich AS, Rinaldi AC - Department. of Biomedical Sciences, University of 
Cagliari, Italy 
 The novel antimicrobial peptide with a dimeric dendrimer scaffold, SB056, was 
empirically optimized by high-throughput screening. This procedure produced an 
intriguing primary sequence whose structure-function analysis is described here. The 
alternating pattern of hydrophilic and hydrophobic amino acids suggests the 
possibility that SB056 is a membrane-active peptide that forms amphiphilic β-strands 
in a lipid environment. Circular dichroism confirmed that the cationic SB056 folds as 
β-sheets in the presence of anionic vesicles. Lipid monolayer surface pressure 
experiments revealed unusual kinetics of monolayer penetration, which suggest lipid-
induced aggregation as a membranolytic mechanism. NMR analyses of the linear 
monomer and the dendrimeric SB056 in water and in 30% trifluoroethanol, on the 
other hand, yielded essentially unstructured conformations, supporting the excellent 
solubility and storage properties of this compound. However, simulated annealing 
showed that many residues lie in the β-region of the Ramachandran plot, and 
molecular-dynamics simulations confirmed the propensity of this peptide to fold as a 
β-type conformation. The excellent solubility in water and the lipid-induced 
oligomerization characteristics of this peptide thus shed light on its mechanism of 
antimicrobial action, which may also be relevant for systems that can form toxic β-
amyloid fibrils when in contact with cellular membranes. Functionally, SB056 showed 
high activity against Gram-negative bacteria and some limited activity against Gram-
positive bacteria. Its potency against Gram-negative strains was comparable (on a 
molar basis) to that of colistin and polymyxin B, with an even broader spectrum of 
activity than numerous other reference compounds. 
26)  Chitosan-carrageenan based polymeric bioabsorbable systems loaded with 
antimicrobial peptides in the management of ascendent cholangytes: an 
overview 
1
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  Treatment of neoplastic or flogistic diseases that cause biliary duct stenosis 
involves extrahepatic biliary duct resection and anastomosis between bile duct stump 
and intestine (Roux-en-Y hepaticojeunostomy). Often this treatment is burden with 
septic complications (cholangites) and anastomotic stenosis. Although mortality of 
no-treated cholangites is near 100%, with proper treatment it is close to 20-25%. 
Similar complications occur in the chronic allograft liver rejection. 
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  Our research group have recently developed a multilayered bioabsorbable 
chitosan-based prosthesis recently patented (MI2011/3425A) granted by Regione 
Emilia-Romagna, Programma di Ricerca Regione-Università,2007-2009. During the 
last three years the research group have obtained significant results about the 
implantation of this prosthesis in preclinical trials on pigs. The results showed the 
efficient and complete biological substitution of prosthesis within 6 months. 
  In an effort to reduce the occurrence of septic complication, the inner layer of 
prosthesis was modified to obtain a composite film loaded with antimicrobial 
peptides for delayed drug release. This composite film was based on chitosan and 
carrageenan solution. Carrageenans are water soluble polymers extracted from red 
algae. They are used in food and pharmaceutical industries as gelling, stabilizing 
agents and immobilization of drugs and enzymes. Several isomers of carrageenan are 
known as k-, l-, and i-carrageenan. The gelling power of K-and L-carrageenans impart 
excellent film forming properties. 
  The k-carrageenan/chitosan composite films were prepared by dissolving the 
carrageenan in distilled water and chitosan solutions was prepared as described in 
patent WO2008/077949. The composite films were prepared in antimicrobial 
peptide/k-carrageenan:chitosan optimal proportion. The film was obtained as 
described in WO2008/077949. 
  The dried composite films were cutted in 5mm-diameter disks and placed in flat-
bottom 96-multiwell plates. 50UL of E.coli strain ATCC 25922 suspension was layered 
onto composite disk. Every 24h, the disk was transferred into another well and 50 uL 
of fresh bacterial suspension was added. The antimicrobial activity was evaluated by 
transferring 20 uL of bacterial suspension onto McConkey agar plates for CFU count. 
After 24h of incubation at 37°C the MIC and LD90 values were obtained. 
  The preliminary results showed a significant reduction of 90-100% CFU load (vs 
control) after two hours of incubation. The drug releasing was sustained for the 
following two weeks with a CFU reduction ranging from 50% (vs control) to 85%. This 
promising results will be further investigated. (granted by Regione Emilia-Romagna, 
Programma di Ricerca Regione-Università,2007-2009) 
 
27)  New insights into the architecture and function of SbmA, an unusual 
transporter of the inner membrane of E. coli 
G. Runti, T. Stoilova, M. Benincasa, R. Gennaro, M. Scocchi - Department of Life Sciences, 
University of Trieste 
 SbmA/BacA is a protein of the inner membrane of many Gram-negative bacteria, 
predicted to be the transmembrane domain of an ABC transport system. sbmA-
deleted E. coli strain shows an increased resistance to the antimicrobial peptide Bac7 
and other proline-rich peptides due to their reduced uptake. In addition, BacA of 
some Gram-negative species is essential to establish chronic infection in animal and 
plant hosts.  
 The aim of this study was to characterize the architecture and function of the 
SbmA transport system in E. coli. By affinity chromatography and fluorescence 
anisotropy assays we showed that SbmA is able to bind Bac7 also without the 
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requirement of a substrate-binding protein. By using a bacterial two-hybrid system 
and in vitro cross-linking assay we showed that SbmA forms dimers both in vivo and 
in vitro. Flow cytometry analysis using different metabolic inhibitors suggests that the 
proton motive force rather than ATP hydrolysis represents the driving force for the 
translocation of peptide substrates.  
 Searching for possible interactors of SbmA, we showed that the yaiW gene, 
located downstream of sbmA, is part of the same operon. The two genes are 
cotranscribed but an interaction between the corresponding proteins has not been 
detected neither at the cytoplasmic nor at the inner membrane level. However, 
ΔyaiW strain showed an increased resistance to Bac7 suggesting the involvement of 
this protein in the SbmA-mediated uptake of the peptide.  
 Overall, these findings suggest that SbmA is an unusual peptide transporter, likely 
derived from the widespread ABC transporters, which has evolutionarily 
lost/changed some typical features of this transport systems, such as the 
requirement of a substrate-binding protein and the energizing source. 
28) In vitro activity of cathelicidins against azole-susceptible and -resistant 
human pathogenic Candida species  
M. Scarsini, L. Tomasinsig, , B. Skerlavaj, A. Arzese and M. Zanetti - Department of 
Medical and Biological Sciences, University of Udine 
 The antimicrobial peptides (AMPs) of innate immunity exert potent and broad-
spectrum antimicrobial activity and have low propensity to select resistant mutants. 
Some (e.g., the human cathelicidin LL-37) may stimulate additional defence 
responses, making AMPs attractive candidates for development as novel antiinfective 
agents combining antimicrobial and immunostimulating properties.  
   Candida spp are the most common cause of vaginal infection, affecting 75% of 
fertile age women with 5-10% incidence of recurrent infections. C. albicans is by far 
the most common species responsible for clinical infections although, less frequent 
species may cause recurrent and persistent infections. The decreased susceptibility 
of Candida spp to currently used antifungals is mainly due to the biofilm-forming 
ability. 
   In this study we have compared the anti-Candida activities of LL-37 and LL-37 
orthologs with those of conventional antifungals, using microdilution susceptibility 
and XTT reduction assays and optical microscopy. The LL-37 ortholog BMAP-28 was 
found to be highly effective against 27 vaginal isolates of Candida spp. (MIC50, 4 
microM) also including azole-resistant strains, and against reference C. albicans 
strains in planktonic and biofilm states, in standard media and in simulated vaginal 
fluid. LL-37 was less effective than BMAP-28 as fungicidal (MIC50, 64 microM) 
although, it prevented Candida biofilm growth by inhibiting cell adhesion to medical 
grade silicone surface. Ongoing toxicity studies on vaginal epithelial cells will allow 
the selection of peptides with the highest anti-Candida activity and lowest 
cytotoxicity. 
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29)  Study of the toxic action of a proline-rich antimicrobial peptide ChBac3.4 
on mammalian cells  
O.Shamova, D.Orlov, T.Pazina, V.Kokryakov - Institute for Experimental Medicine 
Russian Accademy of Medical Sciences 
ChBac3.4 is a proline-rich peptide from goat leukocytes. This peptide appears to 
differ from structurally similar ChBac5 and other proline-rich cathelicidins in virtue of 
its increased ability to damage microbial membranes and to exert toxic effects for 
mammalian cells. We explored the cytotoxic activity of ChBac3.4 towards selected 
tumor and normal human cultured cells in comparison with that of membranolytic 
protegrin 1 (PG1). Unlike PG1, even high concentrations of ChBac3.4 were not 
significantly hemolytic for human erythrocytes. But ChBac3.4 was selectively 
cytotoxic, damaging human K562 erythroleukemia cells, U937 hystiocytic lymphoma 
cells, HL60 promyelocytic leukemia but not normal human skin fibroblasts and some 
other human target cells. The toxic action of PG1 had been occurred within 15-20 
min, while ChBac3.4 demonstrated more delayed effects on cells viability. An 
increase of caspase 3 activity was observed in U937 cells and to a much lesser degree 
in K-562 cells treated with varied concentrations of ChBac3.4. After an incubation of 
U-937 cells with the peptide a significant amount of apoptotic cells was revealed 
using Annexin V-Cy3 apoptosis detection kit; in the case of K-562 line most of the 
cells exposed features of necrosis. We have not observed any signs of apoptosis in 
both types of target cells treated with PG1 in the range of concentration 1.25 – 40 
microM. The proline-rich peptide ChBac3.4 warrants further study, especially with 
respect to its various effects on tumor and normal mammalian cells, and its 
antineoplastic potential. 
30) Membrane-perturbing effects of antimicrobial peptides: a systematic 
spectroscopic analysis 
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 Antimicrobial peptides (AMPs) exhibit a strong activity against a wide range of 
microorganisms, mainly by perturbing the permeability of bacterial membranes 
through the formation of pores. However, AMPs effects on membrane properties 
probably extend beyond pore-formation. We performed a systematic spectroscopic 
analysis of the effects on membrane structure and dynamics of two very different 
AMPs: the cationic PMAP-23, which creates pores according to the “carpet” model,1 
and alamethicin, which forms “barrel-stave” channels.2 By using fluorescence 
anisotropy measurements on liposomes comprising probes localized at different 
depths in the bilayer, we measured peptide effects on membrane fluidity and order. 
Laurdan spectral shifts provided indications about water penetration in the bilayer. In 
the case of PMAP-23, it was possible to focus specifically on the lipids surrounding 
the peptide by following the membrane-probe fluorescence due to FRET from the 
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peptide Trp residues. Finally, peptide-induced perturbation of lateral mobility and 
domain formation were determined by several methods. All experiments were 
compared with liposome-leakage measurements: while for PMAP-23 all membrane-
perturbing effects are correlated with the vesicle leakage process, alamethicin does 
not significantly influence membrane dynamics at the concentrations in which it 
forms pores. Surprisingly, in all cases the most significant peptide-induced effect is a 
reduction in membrane fluidity. 
1. Orioni, B.; Bocchinfuso, G.; Kim, J.Y.; Palleschi, A.; Grande, G.; Bobone, S.; Park, Y.; Kim, J. I.; 
Hahm K.-S.; Stella, L. Biochim. Biophys. Acta 2009, 1788, 1523-1533. 
2. Stella, L.; Burattini, M.; Mazzuca, C.; Palleschi, A.; Venanzi, M.; Baldini, C.; Formaggio, F.; 
Toniolo, C.; Pispisa, B. Chem. Biodivers. 2007, 4, 1299-1312. 
 
31)  Short Peptaibiotics as New Antitumor Agents 
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Padova, 35121 Padova, Italy  
Trichogin GA IV, first isolated from the fungus Trichoderma longibrachiatum [1], 
is the prototype of lipopeptaibols, a sub-class of short-length peptaibiotics exhibiting 
membrane-modifying properties. The primary structure of the 10-amino acid peptide 
trichogin GA IV is as follows:  
n-Oct-Aib1-Gly-Leu-Aib-Gly-Gly-Leu-Aib-Gly-Ile10-Lol 
where n-Oct is n-octanoyl, Aib is α-aminoisobutyric acid, and Lol is the 1,2-amino 
alcohol leucinol. In this work, we synthesized, purified, and fully characterized a set 
of Trichogin GA IV analogues in which the four Gly residues at positions 2, 5, 6, and 9, 
lying on the poorly hydrophilic face of the helical structure, are substituted by one 
(position 2 or 9), two (positions 5 and 6), three (positions 2, 5, and 9), and four 
(positions 2, 5, 6, and 9) strongly hydrophilic Lys residues. Another analogue with the 
triple Lys replacement, characterized by the incorporation of an additional helix-
inducing Aib residue at position 6, was also prepared.  
It is well known that Trichogin GA IV and its synthetic analogues are membrane 
active and that they can induce liposomal permeabilization. In cellular systems red 
blood cell (rbc) haemolysis is a well characterized phenomenon linked to membrane 
destabilization. In addition, cell death induction (cytocidal effect) may represent an 
effective functional assay, since permeabilizing peptides able to form pores or to 
alter the lipid bilayer of the plasma membrane are supposed to induce cell necrosis.  
To study the effects of Trichogin GA IV on eukaryotic cells, several variants of the 
wt Trichogin GA IV have been tested using three in vitro cell-based assays: i. human 
rbc lysis ii. cell mortality assays in total human blood leukocytes and in separate sub-
populations (PMNs, monocytes, macrophages, lymphocytes); iii. cell mortality of four 
tumor-derived stable cell lines (HeLa, A541, A431, HL60). 
The goal was the understanding of the structural features required for cellular 
cytocidal effects and the identification of peptides targeting tumor-derived cells, but 
devoid of haemolytic/leukocydal potentially dangerous side effects, in the 
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perspective of use of Trichogin analogues as anti-tumor drugs. It appears that tumor 
cells are affected by almost all of our Trichogin analogues, while some of them leave 
the leukocytes unaffected. 
1. Auvin-Guette, C.; Rebuffat, S.; Prigent, Y.; Bodo, B. J. Am. Chem. Soc. 114 (1992) 2170-
2174. 
32)  Short-term interaction of the human peptide beta-Defensin 2 (hBD2) with 
dendritic cells explored by SR-IRMS 
Francesca Morgera, Sabrina Pacor, Luisa Creatti, Nikolinka Antcheva, Alessandro 
Tossi, Lisa Vaccari - Department of Life Sciences, University of Trieste and SISSI Beamline, 
Elettra Sincrotrone S C.p.A, Trieste, Italy 
Beta-Defensins are antimicrobial peptides that exert their host-defense functions 
at the interface between the host and microbial biota. They display a direct, salt and 
medium sensitive cidal activity, in vitro, against a broad spectrum of bacteria and 
fungi and there is increasing evidence that they also play a role in alerting and 
enhancing cellular components of innate and adaptive immunity. Their interaction 
with biological membranes plays a central role in both these types of activities. In this 
study we have investigated the interaction of fluorescently labelled human beta-
defensin 2 (hBD2) with monocytes, macrophages and immature dendritic cells, 
observing a differential capacity to be rapidly internalised into these cells. 
Complementary microscopy techniques (TEM, optical and synchrotron radiation 
infrared microspectroscopy) were used to explore the functional and biological 
implications of these interactions on immature dendritic cells. Short-term exposure 
to the peptide resulted in significant alterations in membrane composition and re-
organization of the endomembrane system, with induction of degranulation. These 
events may be associated with the antigen-presenting activities or the chemotaxis of 
iDC, which appears to occur via both CCR6-dependent and independent mechanisms. 
33) The human cathelicidin LL-37: effect of self-aggregation on the mechanism 
of action  
Daniela Xhindoli , Nikolinka Antcheva, Alessandro Tossi - Department of Life Sciences, 
University of Trieste, Italy  
LL-37 is the only member of the cathelicidin family of the antimicrobial peptides, 
found in humans, and is an important multifunctional component of the innate 
immune system. Its direct antimicrobial activity is reportedly due to its ability to 
interact with and to permeabilize bacterial membranes by a detergent-like “carpet” 
mechanism or to the formation of discreet channels. Studies on the evolution of LL-
37 orthologues in primates [1] indicate an important role for oligomerization and 
aggregation that need to be further investigated to elucidate its mode of action. 
Therefore, we have synthesized a photoreactive analog by replacing the Phe in the 
5th position with the unnatural amino acid, p-Benzoyl-L-Phenylalanine (Bpa). 
Irradiation with UV light enables covalent cross-linking, so that self-assembly of the 
LL-37 monomer in PIL buffer could be somehow quantified.  
Another strategy was to synthesize three different disulfide-linked LL-37 dimers 
by adding a Cys residue to either the C- or N-termini, (C- or N-terminal-linked parallel, 
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and antiparallel dimers) as obligatorily aggregated forms. SAR studies revealed that 
the dimeric forms have an increased propensity to form stacked helices in bulk-
solution and when in contact with model membranes, and act differently on both 
bacterial and host cells. We found a lower antimicrobial activity for dimers against 
both Gram-positive and Gram-negative bacteria, so that the generally lower 
antimicrobial activity of LL-37 with respect to its orthologues in the primate such as 
RL-37 may derive from its greater tendency to aggregate. The haemolytic effect was 
different amongst the diverse dimeric forms and particularly high for C-terminal 
dimer.  
Surface Plasmon Resonance was used to study both its self-aggregation and 
interaction with zwitterionic or anionic LUVs. Membrane interaction was found to be 
quite different from that of the mmuRL-37, which tends not to aggregate under the 
conditions used. This comfirmed the importance of conformation and self-
aggregation on the mode of action and biological activity of LL-37. 
[1] I. Zelezetsky, A. Pontillo, L. Puzzi, N. Antcheva, L. Segat, S. Pacor, S. Crovella, A. Tossi J. Biol. 
Chem (2006), 281, 19861 
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Marine invertebrates lack an acquired immunity with a system of antibody 
diversification and rely solely on innate immune mechanisms. The survival of marine 
invertebrate animals in microbe-laden environment suggests that their innate 
immune system is effective and robust. Antimicrobial peptides (AMP) are a major 
component of the innate immune defense system in marine invertebrates. Novel 
AMP from marine organisms could afford design of new antibiotics manifesting 
broad-spectrum antibacterial activity in the presence of physiological or elevated 
NaCl concentrations.  
A new family of small (21-residue) antimicrobial peptides, termed arenicins, was  
discovered in coelomocytes of marine polychaeta lugworm Arenicola marina. These 
AMP exhibit activity against Gram-positive, Gram-negative bacteria and fungi. 
Molecular masses (2758.3 Da and 2772.3 Da) and complete amino acid sequences 
were determined for each isoform. Arenicins have one disulfide bond (Cys3-Cys20). 
In order to determine a high-resolution three-dimensional structure of arenicin-2, the 
recombinant peptide was overexpressed as a fused form in Escherichia coli. Arenicin-
2 in aqueous solution adopts the significantly twisted β-hairpin conformation without 
pronounced amphipathicity. To assess the mechanism of arenicin action, the spatial 
structure and backbone dynamics of the peptide in membrane-mimicking media 
were studied.  
A novel 40-residue antimicrobial peptide, aurelin, exhibiting activity against 
Gram-positive and Gram-negative bacteria, was purified from the mesoglea of a 
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scyphoid jellyfish Aurelia aurita. Molecular mass (4296.95 Da) and complete amino 
acid sequence of aurelin were determined. Aurelin has six cysteines forming  three 
disulfide bonds. To our knowledge, aurelin is the first AMP isolated from cnidarians 
(class Scyphozoa). Aurelin reveals partial similarity both with defensins and K+ 
channel blocking toxins of sea anemones and belongs to ShKT domain family. 
Overlapping of biological properties of marine animal AMP and toxins along with 
their sequence homology might be a consequence of divergent evolution from a 
common ancestor. Recombinant aurelin and its 15N-labeled analogue were 
overexpressed in E. coli and purified. The spatial structure, backbone dynamics and 
interaction of aurelin with lipid vesicles and detergent micelles were studied. 
35) Trans2Care project 
Sabina Passamonti, Renato Gennaro - Department of Life Sciences, University of Trieste, 
Italy  
Trans2Care is a joint project of academic, research, healthcare and technology 
transfer institutions from Italy and Slovenia, with University of Trieste as leading 
partner. The network works in tight cooperation with industry and end-users, in 
order to address unmet medical needs. 
Trans2Care’s mission is to promote knowledge dissemination and technology 
transfer, favouring innovative practices and products for disease prevention, early 
diagnosis, personalized therapies.  
The objectives are to set up a shared, cross-border network of institutions 
dedicated to the permanent development of new protocols and biotechnological 
devices for the prevention, early diagnosis and cure of neurodegenerative, 
cardiovascular, orthopaedic, infective and oncologic diseases. 
Within Trans2care, groups at Trieste and Udine Universities and Valdotra 
Orthopaedic hospital are working on the development and transfer of novel 
applications for antimicrobials. 
 
36)  Innovaqua project 
Michela Furlan, Lucia Corich, Marco Scocchi and Sabina Passamonti - Department of 
Life Sciences, University of Trieste, Italy. 
Innovaqua is a network of 8 partners, including academic institutions 
(Universities of Trieste -  Lead Partner, Udine, Padova and Nova Gorica), research 
institutions (Istituto Zooprofilattico delle Venezie, Slovenian Chamber of Agriculture 
and Forestry) and companies related to aquaculture (Vodomec d.o.o., Shoreline soc. 
coop.).  
The project coordinates the sharing knowledge and training young researchers on 
various aspects of fish farming, including management and prophylaxis of infectious 
diseases, actively involving them in knowledge transfer to fish farmers. 
The human resources involved in the project include team managers, researchers 
and industry experts, and are divided into working groups that share technologies 
and research methodologies.  Four of these are collaborating in the development of 
endogenous antimicrobial peptides (AMPs) from trout and sea bass as novel vaccine 
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adjuvants for use in the control of infectious diseases in economically important fish 
stocks. 
The Innovaqua project is funded by the Cross-border Cooperation Programme 
Italy-Slovenia 2007-2013 (call 2/2009 for standard projects), financed by the both the 
European Regional Development Fund (85%) and national funds(15%). 
 
Finito di stampare nel mese di maggio 2012
presso la Ripartizione Comunicazione Istituzionale e Organizzazione Eventi
dell’Università degli Studi di Trieste
per conto di EUT – Edizioni Università di Trieste
